## TSCA W ork P lan Chemical

Problem Formulation and Initial Assessment

1,4

- Dioxane CASRN: 123

- 91

- 1

April 201 5 United States Environmental Protection Agency EPA Document# 740

- R1

- 5003 April 2015 Office of Chemical Safety and Pollution PreventionPage 2 of 54 

## TABLE OF CONTENTS

TABLE OF CONTENTS

................................ ................................ ................................ ......................... 2 AUTHORS / CONTRIBUTO RS / ACKNOWLEDGEMENT S

................................ ................................ ....... 4

ABBREVIATIONS

................................ ................................ ................................ ................................ 5

EXECUTIVE SUMMARY

................................ ................................ ................................ ...................... 7

1 INTRODUCTION

................................ ................................ ................................ ........................ 10

1.1 S COPE OF THE A SSESSMENT

................................ ................................ ................................ ............................ 11 1.2 R EGULATORY AND A SSESSMENT H ISTORY

................................ ................................ ................................ .......... 12

2 PROBLEM FORMULATION

................................ ................................ ................................ ........ 14

2.1 P HYSICAL AND C HEMICAL P ROPERTIES

................................ ................................ ................................ .............. 14 2.2 P RODUCTION AND U SES

................................ ................................ ................................ ................................ . 1 5 2.3 F ATE AND T RANSPORT

................................ ................................ ................................ ................................ ... 19 2.4 E XPOSURES

................................ ................................ ................................ ................................ .................. 21 2.4.1 Releases to the Environment

................................ ................................ ................................ ................ 21 2.4.2 Presence in the Environment

................................ ................................ ................................ ................ 21 2.4.3 Occupational Exposure

................................ ................................ ................................ ......................... 23 2.4. 4 General Population Exposure

................................ ................................ ................................ ............... 25 2.4.5 Consumer Exposure

................................ ................................ ................................ .............................. 27 2.5 H AZARD E NDPOINTS

................................ ................................ ................................ ................................ ...... 28 2.5.1 Environmental Hazard

................................ ................................ ................................ .......................... 28 2.5.2 Human Health Hazard

................................ ................................ ................................ .......................... 28 2.6 R ESULTS OF P ROBLEM F ORMULATION

................................ ................................ ................................ .............. 30 2.6.1 Conceptual Model

................................ ................................ ................................ ................................ 30 2.6.2 Anal

ysis Plan

................................ ................................ ................................ ................................ ........ 33 2.6.3 Uncertainties and Data Gaps

................................ ................................ ................................ ............... 34
REFERENCES

................................ ................................ ................................ ................................ .... 35

APPENDICES 40 Appendix A Regulatory and Assessment History

................................ ................................ ............ 40 Appendix B Summary of Uses and End Products

................................ ................................ ............ 43 Appendix C Occupational Exposure Data

................................ ................................ ....................... 44 Appendix D Ecological Hazard Studies

................................ ................................ ........................... 46

D

- 1 A CUTE T OXICITY TO A QUATIC O RGANISMS

................................ ................................ ................................ ..... 46 D

- 2 C HRONIC T OXICITY TO A QUATIC O RGANISMS

................................ ................................ ................................ .. 48 D

- 3 T ERRESTRIAL P LANTS T OXICITY

................................ ................................ ................................ ...................... 49 D

- 4 S OIL I NVERTEBRATE AND A VIAN T OXICITY

................................ ................................ ................................ ....... 49 Appendix E Human Health Hazard Studies

................................ ................................ .................... 50

E

- 1 A CUTE T OXICITY S TUDIES

................................ ................................ ................................ ............................. 50Page 3 of 54

E

- 2 R EPEATED

- D OSE T OXICITY S TUDIES

................................ ................................ ................................ ............... 50 E

- 3 R EPRODUCTIVE AND D EVELOPMENTAL T OXICITY S TUDIES

................................ ................................ .................. 51 E

- 4 S KIN I RRITATION AND S ENSITIZATION S TUDIES

................................ ................................ ................................ . 51 E

- 5 G ENOTOXICITY AND C ANCER S TUDIES

................................ ................................ ................................ ............ 51

LIST OF TABLES
Table 2

- 1: Physical and Chemical Properties of 1,4

- Dioxane.

................................ ................................ .. 15 Table 2

- 2: 1986

- 2012 National Production Volume Data for 1,4

- Dioxane (Millions of Pounds).

............ 15 Table 2

- 3: CDR Industrial and Consumer Use Data.

................................ ................................ ................. 18 Table 2

- 4: Environmental Fate Endpoints for 1,4

- Dioxane.

................................ ................................ ..... 20 Table 2

- 5: Exposure Concentrations for Occupational Scenarios in European Industri al and Laboratory Facilities.

................................ ................................ ................................ ................................ ................... 24 Table 2

- 6: Preliminary Data from the EPA UCMR 3 (January 2015).

................................ ........................ 26 Table A 1: History of Regulatory and Assessment Actions in the U.S. and Internationally ......................39 Table B

- 1: Summary of All Uses of 1,4

- Dioxane and End Products

................................ .......................... 43 Table C

- 1: Summary of 1,4 Dioxane Occupational Monitoring Data for Process Operators in the Synthesis Area from an ACC Member Company where 1,4

- Dioxane is Produced as a Byproduct in its Manufacturing Process .........................................................................................................................................43 Table C

- 2: 1,4

- Dioxane

- OSHA Chemical Exposure Health Data, 1997

- 2011 .............................................45 Table D

- 1: Aquatic Toxicity Data for 1,4

- Dioxane

- Acute Tox icity .................................................................47 Table D

- 2: Aquatic Toxicity Data for 1,4

- Dioxane

- Chronic Toxicity .............................................................48 Table E

- 1: Human Health Endpoints for 1,4

- Dioxane ......................................................................................53

LIST OF FIGURES Figure 2

- 1: Chemical structure of 1,4

- dioxane.

................................ ................................ ........................ 14 Figure 2

- 2: Conceptual Model of Potential Exposure Pathways for 1,4

- Dioxane.

................................ ... 31Page 4 of 54 

## AUTHORS / CONTRIBUTORS / ACKNOWLEDGEMENTS

This report was developed by the United States Environmental Protection Agency (US EPA), Office of Chemical Safety and Pollution Prevention (OCSPP), Office of Pollution Prevention and Toxics (OPPT). The Work Plan Chemical Problem Formulation for 1,4

- dioxane was prepared based on currently available data. Mention of trade names does not constitute endorsement by EPA.

EPA Assessment Team Leads : Katherine Anitole, OPPT/Risk Assessment Divi sion (RAD) Susan A. Laessig , OPPT/RAD

Team Members : Nishkam Agarwal, OPPT/ Chemistry, Economics and Sustainable Strategies Division ( CESSD ) Christina Cinalli (retired), OPPT/RAD Ana Corado , OPPT/Environmental Assistance Division (EAD) Joe Ford, OPPT/RAD Amuel Kennedy, OPPT/RAD Scott Prothero, OPPT/RAD Teresa Washington, OPPT/RAD

Management Leads : Yvette Selby

- Mohamadu , OPPT/RAD Todd Stedeford, OPPT/RAD

Contract S upport Technical support for portion s of this document was provided by Abt Associates, Inc. under EPA Contract No. EP

- W

- 08

- 010.

Docket Please visit the public docket ( www.regulations.gov ; Docket: EPA

- HQ

- OPPT

- 201 5

- 0078 ) to view supporting information.Page 5 of 54 

## ABBREVIATIONS

ACC American Chemistry Council ACGIH American Conference of Government Industrial Hygienists AEGL Acute Exposure Guideline Level A ES Alkyl ethoxy sulphates ATSDR Agency for Toxic Substances and Disease Registries BCF Bioconcentration factor CAA Clean Air Act CASRN Chemical Abstract Service Registry Number CBI Confidential Business Information CCL Candidate Contaminant List CDR Chemical Data Reporting CPSC Consumer Product Safety Commission CSF Cancer Slope Factor EC European Commission ECHA European Chemicals Agency EPA Environmental Protection Agency EU European Union EUSES European System for the Evaluation of Substances FDA Food and Drug Administration HEAA 

- hydroxyethoxy acetic acid Hg Mercury HHS Department of Health and Human Services HPV High Production Volume IARC International Agency for Research on Cancer IRIS Integrated Risk Information System IUR Inventory Update Reporting Rule ; Inhalation Unit Risk kg Kilogram(s) K OW Octanol:Water partition coefficient lb Pound LOEC Lowest Observed Effect Concentration LOEL Lowest Observed Effect Level Log K OW Logarithmic Octanol:Water partition coefficient MATC Maximum Acceptable Toxicant Concentration
mg Milligram(s) MOE Margin of Exposure MRL Minimal Risk Level NIOSH National Institute of Occupational Safety and Health NOEC No Observed Effect Concentration NOAEL No Observed A dverse E ffect L evel NPL National Priorities List NTP National Toxicology ProgramPage 6 of 54

OAR Office o f Air and Radiation OCSPP Office of Chemical Safety and Pollution Prevention OECD Organisation for Economic Co

- operation and Development OPPT Office of Pollution Prevention and Toxics OSHA Occupational Safety and Health Administration OSWER Office of Solid Waste and Emergency Response OW Office of Water PBPK Physiologically Based Pharmacokinetic PBT Persistent, Bioaccumulative
, Toxic PDE Permitted Daily Exposure PEC Predicted Environmental Concentration PEL Permissible Exposure Level
p pb Parts per billion
ppm Parts per million PV Production Volume PWS Public Water System RA Risk Assessment RAR Risk Assessment Report REACH Registration, Evaluation, Authorisation and Restriction of Chemicals REL Recommended Exposure Level RfC Reference Concentration RfD Reference Dose TCA 1,1,1

- trichloroethane TLV Threshold Limit Value TRI Toxic Release Inventory TSCA Toxic Substances Control Act UCMR Unregulated Contaminant Monitoring Rule US United States WHO World Health Organisation WWTP Wastewater Treatment Plant Y r YearPage 7 of 54



## EXECUTIVE SUMMARY

As part of EPA’s comprehensive approach to enhance the Agency’s management of existing chemicals, in March 2012 EPA/OPPT identified a work plan of chemicals for further assessment under the Toxic Substances Control Act (TSCA) 1

. Chemical risk assessments will be conducted if, as a result of scoping and problem formulation, there are exposures of concern, identified hazards a nd sufficient data for quantitative analysis. If an assessment identifies unreasonable risks to humans or the environment, EPA will pursue risk management. This document presents the problem formulation and initial assessment for 1
, 4

- dioxane as part of the TSCA Work Plan
program

.
The conclusions from this problem formulation and initial assessment are that:

 EPA/OPPT will further assess potential risks to workers exposed during product formulation and use as a cleaning agent.

 EPA/OPPT will further assess potential risks to workers and consumers exposed during the use of TSCA

- use products that contain 1,4

- dioxane as a contaminant , such as paints, varnishes, adhesives, cleaners and detergents.

 R isk to the general population through inhalation exposure to am bient air emissions is estimated to be low

.

 An assessment of risk from exposure through drinking water is not needed at this time because 1,4

- dioxan e is currently being monitored and EPA will determine whether or not regulatory action is needed as part of EPA ’s Regulatory Determination process.

 Based on the low hazard profile for 1,4

- dioxane to aquatic organisms, risks to these organisms are expected to be low. Lack of hazard data for sediment and soil organisms precludes determination of risk to these env ironmental compartments. Therefore, f urther analysis of environmental risk is not planned.

1,4

- Dioxane is an industrial solvent used in the production of a wide variety of products, as a laboratory reagent, a chemical intermediate, an extraction medium f or fats and oils, and as part of a polymerization catalyst

. Other uses of 1,4

- dioxane are in commercial and consumer products such as lacquers, varnishes, paint strippers, dyes, greases, cleaners and detergents, adhesives, cosmetics and deodorants. 1,4

- Dio xane is also present as an unintended byproduct in cosmetics, detergents, and shampoos. Historically, 90% of all 1,4

- dioxane was used as a stabilizer in chlorinated solvents such as 1,1,1

- trichloroethane (TCA). Use of 1,4

- dioxane has decreased since 1,1,1

- trichloroethane was phased out by the Montreal Protocol in 1996 for all uses except a few select applications. In the 1980’s and early 1990’s, 10 to 50 million pounds were manufactured yearly and f rom 1994 to 2006, the yearly U.S. production volume of 1,4

-

1 http://www.epa.gov/oppt/existingchemicals/Page 8 of 54

dioxane has been 1 to 10 million pounds. Recent data show that 1.1 million pounds is released to the environment.

During scoping and p roblem f ormulation, EPA/OPPT r eviewed previous risk assessments and additional published studies on the fate, exposure and hazard of 1,4

- d ioxane

. EPA/OPPT examined likely exposure and hazard scenarios based on current production, use, and fate information to identify scenarios amenable to risk analysis. The s cenarios considered were:

 Workers potentially exposed during ma nufacturing and formulation of 1,4

- dioxane or in industrial or laboratory facilities where 1,4

- dioxane is used

.

 W orkers and consumers potentially exposed during the use of products that contain 1,4

- dioxane as a contaminant

.

 The g eneral population potentially exposed via i nhalation of ambient air receiving emissions from manufacturing/formulating facilities
, as well as incineration of waste streams/products

.

 The general population potentially exposed to 1,4

- dioxane through contaminat ed drinking wat er

. The routes of potential human exposure to 1,4

- dioxane are inhalation, ingestion and dermal
contact. D ermal exposures are not addressed due to high volatilization, low absorption and lack of dermal toxicity st udies

. Potential human health effects from i nhalation and ingestion include

cancer and noncancer outcomes (liver, kidney and nasal effects) in workers, consumers and the general population.

EPA/OPPT reviewed the ecological hazards of 1,4

- dioxane and determined that a cute and chronic hazard is low for aquatic species

. There are no sediment or soil toxicity data to assess the hazard to organisms in these environmental compartments

. A conceptual model was not developed for environmental health and further analysis of environmental risk is not planned

.

Th e results of p roblem f ormulation as illustrated in the c onceptual m odel for human health and described under the a ssessment q uestions indicate that:

 A 2002 European assessment found p otential risk to workers for occupational exposures via the dermal and inhalation routes during product formulation and the use of 1,4

- dioxane as

a cleaning agent. Availability of EPA’s recently updated benchmarks for human health suggest that human health risks should be reassessed. While US data on occupational exposures are limited, EPA/OPPT will f urther assess the risk to workers from inhalation of 1,4

- dioxane during manufacture, formulation and use of products using available data or modeled exposures in the absence of data

.

 Work ers and consumers may be exposed to 1,4

- dioxane present as a contaminant in products such as personal care products, paint s , adhesives, varnish es , cleaners and detergent s

. R isk assessments in Canada and Europe concluded that levels of contamination do not pose concerns for human health. While personal care products are regulated by thePage 9 of 54

FDA, uses in paints, adhesives, varnish es , cleaners and detergent s fall under TSCA authority. Availability of EPA’s recently updated benchmarks for human health suggest that human health risks should be reassessed. Therefore, EPA/OPPT plans to further assess potential risks posed to consumers by 1,4

- dioxane in products covered under TSCA.

 The general population may be exposed from inhalation to ambient levels of 1,4

- dioxane i n air

. R egulations for air pollution are in place through the Clean Air Act (CAA)

. 1,4

- D ioxane is short lived in the environment and historical ambient air levels of 1,4

- dioxane are considered low

. R isk assessments in Canada and Europe concluded that there are no risks of concern from exposure to 1,4

- dioxane in ambient air. Given that 1,4

- dioxane is regulated under the C A A as a hazardous air pollutant ( US EPA, 2000 ) and EPA/OPPT’s comparison of historical air concentrations of 1,4

- dioxine against the recent EPA IRIS benchmarks (RfC and IUR) indicate these concentrations are below levels of concern, a ssessment of general population exposure to 1,4

- dioxane in ambient air will not be further analyzed by EPA/OPPT under TSCA

.

 The general population may be exposed to 1,4

- dioxane in contaminated drinking water

. EPA ’s Office of Water is currently monitoring public drinking water systems in order t o evaluate the risk to defined population s

. P otential source contributions to drinking water

are uncertain

. Since 1,4

- dioxane is being monitored through December 2015, d ecisions as to whether or not to regulate the contaminant in drinking water will be considered as part of the EPA ’s Regulat ory Determination process. In summary, a s a result of problem formulation, EPA/OPPT plans to conduct additional risk analysis on potential worker and consumer exposures under the TSCA Existing Chemicals Program using existing data and methods

. EPA/OPPT plans to carefully review and evaluate the results o f previous exposure assessments and health benchmarks. EPA will develop margins of
exposure and cancer risk estimates to evaluate the potential risks from worker and co nsumer exposure to 1,4

- dioxane. EPA does not have risk concerns for the general population through inhalation exposure to ambient air emissions.Page 10 of 54



## 1 INTRODUCTION

As a part of EPA’s comprehensive approach to enhance the Agency’s management of existing chemica ls, in March 2012 EPA/OPPT identified a work plan of chemicals for further assessment under the Toxic Substances Control Act (TSCA) 2 . After gathering input from stakeholders, EPA/OPPT developed criteria used for identifying chemicals for further assessment 3 . The criteria focused on chemicals that meet one or more of the following factors: (1) potentially of concern to children’s health (for example, because of reproductive or developmental effects); (2) neurotoxic effects; (3) persistent, bioaccumulative an d toxic (PBT); (3) probable or known carcinogens; (4) used in children’s products; or (5) detected in biomonitoring programs. Using this methodology, EPA/OPPT identified a TSCA Work Plan of chemicals as candidates for risk assessment in the next several ye ars. In the prioritization process, 1,4

- dioxane was identified for assessment based on classification as a probable human carcinogen, wide use in consumer products, high reported releases to the environment, and presence in groundwater, ambient air and ind oor environments.

EPA/OPPT is performing risk assessments on chemicals in the work plan. If an assessment identifies unacceptable risks to humans or the environment, EPA will pursue risk management. The target audience for th e final risk assessment is primarily EPA risk managers; however, it may also be of interest to the broader risk assessment community as well as US stakeholders interested in 1,4

- dioxane. The information presented in the risk assessment may be of assistance to othe r f ederal, s tate and l ocal agencies as well as to members of the general public who are interested in understanding whether there are risks from exposure to 1,4

- dioxane.

The initial step in the EPA/OPPT risk assessment development process, which is disti nct from the initial prioritization exercise, includes planning, scoping and problem formulation. During these steps EPA/OPPT may review currently available data and information, including but not limited to, assessments conducted by others (e.g., authorit ies in other countries), publish ed or readily available reports and published scientific literature. The problem formulation data review could result in refinement of pathways of interest previously identified in the initial prioritization.

This document includes the results of scoping
, problem formulation , and initial assessment for 1,4

- dioxane . In the scoping stage
, EPA/OPPT determin ed which chemical(s) to include and what

uses to consider in the assessment . During pr oblem formulation
, EPA/OPPT identified available fate, exposure and hazard data, and characterized potential exposure s , receptors and effects

. EPA/OPPT developed a conceptual model and an analysis plan as a result of problem formulation

.

2 http://www.epa.gov/oppt/existingchemicals/pubs/workplans.html
3 http://www.epa.gov/oppt/existingchemicals/pubs/wpmethods.pdfPage 11 of 54



### 1.1 Scope of the Assessment

The TCSA W ork P lan chemical 1,4

- dioxane is a high production volume chemical (up to 10 million lbs/yr, based on publicly available information), has a variety of industrial uses and may be present in both consumer and commercial products

. 1,4

- Dioxane is use d as an industria l solvent in the production of a wide variety of product s , as a laboratory reagent, a chemical intermediate, an extraction medium for fats and oils and as part of a polymerization catalyst ( ATSDR, 2012 )

. 1,4

- dioxane is also used in commercial and consumer products such as lacquers, varnishes, paint strippers, dyes, greases, cleaners and detergent s , adhesives, cosmetics and deodorant s ( European Chemicals Bureau, 2002 ; US EPA, 2014d )

. In addition, 1,4

- dioxane is present as a contaminant in consumer cosmetics/toil etries, household detergents, pharmaceuticals, foods, agric ultural and veterinary products and ethylene glycol

- based antifreeze coolants
, because it is a byproduct of certain ethoxylated substances ( ATSDR, 2012 )

.
Workers, consumers and the general population may be expose d to 1,4

- dioxane by inhalation, ingestion and dermal routes . Because 1,4

- dioxane is not intentionally added to consumer products, only workers are exposed to products which intentionally contain 1,4

- dioxane. Inhalation is expected to be the predominant route of exposure due to the high vapor pressure and volatility of 1,4

- dioxane. W orkers and c onsumers may be expo sed to products that contain 1,4

- dioxane as an unwanted byproduct or an interme diate that is not fully reacted and t he concentrations of 1,4

- dioxane in these cases are lower, usually measured in parts per million or less. T he general population may be expo sed environmentally from air or water containing 1,4

- dioxane.

Absorption of 1,4

- d ioxane occurs readily through the lungs and gastrointestinal system and poorly through the skin. After absorption, 1,4

- d ioxane is rapidly eliminated from the body and does n ot accumulate. EPA classifies 1,4

- dioxane as “likely to be carcinogenic to h umans” by all routes of exposure based on liver tumors in rats and mice following chronic drinking water
exposure ( US EPA, 2013b ) . Nasal tumors were observed in rats following chronic inhalation or drinking water exposure. Short

- term exposure may result in irritation of th e eyes and t hroat ( ATSDR, 2012 ) and c hronic exposure may result in dermatitis, eczema, drying and cracking of skin, and liver and kidney damage ( ATSDR, 2012 )

.
In the environment, 1,4

- dioxane partitions to water and is highly mobile in soil. 1,4

- Dioxane is highly volatile, has a short re sidence time in air and does not readily biodegrade in water. Toxicity to aquatic organisms is not expected based on low hazard values

.

Given the common use , widespread exposure and potential human health hazards of 1,4

- dioxane
, EPA/OPPT conducted a probl em formulation an d evaluation of readily available data and information to determine the exposures and hazards of interest for risk assessment. Available data w ere used including chemical structure, physical chemistry, production volume,Page 12 of 54

reported uses and toxicological information from existing assessments to develop a conceptual model and an analysis plan

.



### 1.2 Regulatory and Assessment History

EPA/OPPT reviewed and considered the regulatory and assessment history of 1,4

- dioxane ( Appendix A : Regulatory and Assessment History )

. National (U.S.) 1,4

- Dioxane is a known animal carcinogen according to the National Toxicology Program (NTP) ( NTP, 2014 )

. The US Department of Health and Human Services ( D HHS) considers 1,4

- dioxane as reasonably anticipated to be a human carcinogen ( US DHHS, 1993 ) . EPA has determined that 1,4

- dioxane is likely to be carcinogenic to human s ( US EPA, 1999 )

.
Occupational exposure limits have been set by federal agenci es and organizations in the US (OSHA, NIOSH, ACGIH) and are summarized in Appendix A

. A recent Toxicological Profile for 1,4

- dioxane ( ATSDR, 2012 ) provided a detailed analyses of available hazard data. The data were used to derive minimal risk levels (MRLs), exposure levels posing minimal risk to humans, for inhalation and oral exposures. The EPA Integrated Risk Information System (IRIS) Program recently update d the assessment of 1,4

- dioxane
, including the results of a two

- year inhalation bioassay ( US EPA, 2013b ) . IRIS developed cancer and non

- cancer reference values for inhalation and drinking water exposure. Acute Exposure Guideline Levels (AEGLs) for 1,4

- dioxane have been established ( NAS/COT Subcommittee for AEGLs, 200 5 ) . The MRLs, IRIS benchmarks and AEGLs are provided in Appendix A

.
The Food and Drug Administration (FDA) does not require 1,4

- dioxane to be listed on labels of personal care products and considers it a contaminant

. FDA has indicated that the levels o f 1,4

- dioxane found in their monitoring of cosmetics do not present a hazard to consumers and recommended a level of 3.8 mg/day (380 ppm ) as the “permitted daily exposure (PDE)” for 1,4

- dioxane that is an acceptable intake of residual solvents in drugs and dietary supplements ( US FDA, 2 011 )

. FDA limits 1,4

- dioxane levels in glycerides and polyglycerides of hydrogenated vegetable oils used as a food additive to 10 mg/kg.

Industries manufacturing, processing or using 1,4

- dioxane are legally required to report releases to EPA’s Toxic Re lease Inventory (TRI) if they manufacture or process more than 25,000 pounds of a TRI

- listed chemical or otherwise use more than 10,000 pounds of a listed chemical in a given year.

The EPA Office of Water (OW) has included 1,4

- dioxane on the third Candidate Contaminant List (CCL3). No federal drinking water standards have been established for 1,4

- dioxane and i t is being monitored in public water systems as part of the Unregulated Contaminant Monitoring Rule 3 (UCMR3) list. OW is conducting a t hree

- year (2013

- 2015) monitoring program of public water systems to collect data for contaminants suspected to be present in finished drinkingPage 13 of 54

water includ ing 1,4

- dioxane (USEPA, 2013). Information about UCMR3 and 1,4

- dioxane monitoring in Public Water Sys tems (PWS) can be found at: http://water.epa.gov/lawsregs/rulesregs/sdwa/ucmr/data.cfm

. EPA’s Office of Air and Radiation (OAR) regulate s 1,4

- dioxane as a Hazardous Air Pollutant ( http://www.epa.gov/ttn/uatw/hlthef/dioxane.html ). EPA’s Office of Solid Waste and Emergency Response (OSWER) regulates the Superfund sites that are historically a source of 1,4

- dioxane in groun d water around those sites. 1,4

- Dioxane has been reported at 32 National Priorities List (NPL) sites ( http://www.atsdr.cdc.gov/SPL/index.html ). Examples include sites in New Hampshire ( http://www.epa.gov/region1/removal

- sites/NH14DioxaneSite.html ) and Massachusetts ( http://www.epa.gov/re gion1/superfund/sites/graceacton/507061.pdf ).

State s 1,4

- Dioxane is listed on California’s Proposition 65 list because it is known to cause cancer ( CA EPA OE HHA, 2007 , 2014 ) . The action level under California Prop osition 65 for 1,4

- dioxane in personal care products is above 10 ppm. California also lists 1,4

- dioxane on the Informational “Initial” Candidat e Chemicals List and the Informational Candidate Chemicals List under California’s Safer Consumer Products regulations ( State of California, 2010 ) . Further, Minnesota and Washington classify 1,4 dioxane as a chemical of high concern ( Minnesota Department of Health (MDH), 2013 ; Washington State, 2013 )

.

International The International Agency for Researc h on Cancer (IARC) has determined that 1,4

- dioxane is possibly carcinogenic to humans ( IARC, 1976 ) based on inadequate evidence in humans and sufficient evidence in experimental animals

. A Canadian screening assessment ( Environment Canada and Health Canada, 2010 ) evaluated the risk of 1,4

- dioxane to human health . Ecological risks were not assessed since 1,4

- dioxane did not meet the criteria for bioaccumulation and inherent toxicity to aquatic organisms. Exposures to the general population from intake from air, water, soil, diet , use of personal care products and household products were estimated. The report concluded that 1,4

- dioxane is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.
The European Uni on Risk Assessment Report (EU RAR, 2002) concluded that there is no concern for human safety with regard to repeated

- dose toxicity, carcinogenici ty and reproductive toxicity. The assessed risk concern was low for the general population (inhalation and drin king water), direct and indirect consumer exposures in cosmetic/toilet ries and household detergents, pharmaceuticals, foods, agricultural and veterinary products, and ethylene g lycol

based antifreeze coolants and ecological exposures

. A potential risk conc ern for workers was found for occupational exposures via the dermal and inhalation routes during product formulation and the use of clean ing agents containing 1,4

- dioxane

.Page 14 of 54



## 2 PROBLEM FORMULATION

P roblem formulation aims to determine the major factors to be considered in an assessment, including exposure pathways, receptors and health endpoints ( US EPA, 1998 , 2014b )

. Accordingly
, this problem formulation summarizes the exposure pathways, receptors and health endpoints that EPA/OPPT considered to determine whether to conduct further risk analysis and what exposure/hazard scenarios to include in a potential risk assessment . To make this determination, EPA/OPPT conducte d a preliminary data review to identify available fate, exposure and hazard data and determine its likely suitability for quantitative analysis and to identify exposure pathways, receptors and health endpoints for quantitative analysis.

The outcome of th is evaluation is summarized in a conceptual model ( Figure 2

- 2 ) that illustrate s the exposure pathways, receptor s and effects that were considered for potential risk
assessment. An analysis plan is developed if the results of p roblem f ormulation indicate the need for further analysis.



### 2.1 Physical and Chemical Properties

1,4

- Dioxane is a clear liquid at room temperature . The cyclic structure ( Figure 2

- 1 ) has oxygen molecules attached at the first and fourth b onds, each with free electrons ( US EPA, 2006b )

. 1,4

- D ioxane is expected to volatilize from dry soil surfaces based on its high vapor pressure (40 mm Hg at 25 °C) ( US EPA, 2009 )

. 1,4

- Dioxane has a Log K ow value of

- 0.27, which indicates that this chemical is hydrophilic
, readily miscible in water ( US EPA, 2009 )

. A summary of the physical and chemical properties of 1,4

- dioxane are listed in Figure 2

- 1

.

Figure 2

- 1 : Chemical structure of 1,4

- dioxane.Page 15 of 54

Table 2

- 1 : Physical and Chemical Properties of 1,4

- Dioxane.

Property Value References Molecular Weight 88.1 g/mol ( Howard, 1990 ) Melting Point 11.85 °C (measured) ( Lide, 2008

- 2009 ) Boiling Point 101.1 °C (measured) ( O'Neil et al., 2006 ) Vapor Pressure 40 mm Hg at 25 °C ( Lewis, 2000 ) Water Solubility ˃ 8.00 × 10 2 g/L ( Yalkowsky and He, 2003 ) Log K OW - 0.27 ( Hansch et al., 1995 ) Henry’s Law Constant 4.8 × 10 - 6 atm

- m 3 /mol at 25 °C ( Howard, 1990 )



### 2.2 Production and Uses

The EPA’s Inventory Update Reporting (IUR) a nd 2012 Chemical Data Reporting (CDR) database s were searched to identify the uses and associated production volumes of 1,4

- dioxane. Some information was claimed as Confidential Business Information (CBI) and is not included in this report. Additional info rmation on uses and specific end products that may contain 1,4

- dioxane can be found in Appendix B: Summary of Uses and End Products

.

Production In 2006, the U.S. production volume of 1,4

- dioxane was between 1 million and 10 million pounds, including both imports and domestic manufacture ( US EPA, 2010 ) . Data from the 2012 CDR for reporting years 2010 and 2011 were claimed as CBI and indicate only domestic manufacture of 1,4

- dioxane ( US EPA, 2014c ) . The non

- confidential U.S. production volumes of 1,4

- dioxane, as submitted by companies under the IUR or CDR for 1986 to 2012, are given in Table 2

- 2

.

Table 2

- 2 : 1986

- 2012 National Production Volume Data for 1,4

- Dioxane (Millions of Pounds).

Uses 1,4

- D ioxane is currently used as both an industrial and a commercial solvent. As a result of chemical ethoxylation of surfactants, 1,4

- dioxane can be formed as a byproduct and may be present as a contaminant in commercial and consumer products . Historically, the main use of 1986 IUR 1990 IUR 1994 IUR 1998 IUR 2002 IUR 2006 IUR 2012 CDR

10

- 50 10

- 50 1

- 10 1

- 10 1

- 10 1

- 10 Withheld Source: ( US EPA, 2006a , 2010 , 2012b )Page 16 of 54

1,4

- dioxane (90 percent) was as a stabilizer in chlorinated solvents such as 1,1,1

- trichloroethane (TCA). Use of TCA was phased out under the 1995 Montreal Protocol and the use of 1,4

- dioxane as a stabilizer is no longer significant ( European Chemicals Bureau, 2002 ; NTP, 2014 )

.

Industrial Uses. At present, 1,4

- dioxane is used as a n industrial solvent in the manufacture of chemicals because it is capab le of solubilizing most organic and many inorganic compounds ( ATSDR, 2012 ; Ullman's, 2012 )

. As an industrial solvent, 1,4

- dioxane is used as :

 a processing solvent

 a reaction medium solvent

 a n industrial solvent with an unspecified function in the production of various end products ( ATSDR, 2012 ; US EPA, 20 06a )
Other industrial uses include :

 as an extraction medium

 an inert (chemically inactive) ingredie nt in pesticides and fumigants

 a chemical intermediate

 a polymerization catalyst

 a dehydrating agent

 a wetting and dispersing agent

 a degreasing agent ( ATSDR, 2012 ; US EPA, 2006a )

Appendix B lists example s of end products for each of these industrial uses. Table 2

- 3 provides th e industrial use data as reported in the 2012 CDR database 4

.

Commercial and Consumer Uses. As an industrial processing solvent or chemical intermediate, 1,4

- dioxane has previously been reported to be used in the production of products that may have commercial or consumer applications such as paints, adhesives, detergents, and pesticides ( ATSDR, 2012 ; US EPA, 2006a , 2014c )

. In the most recent CDR database, no consumer uses were reported for 1,4

- dioxane in the US ( Table 2

- 3 ). Additional US sources do not di fferentiate between consumer and commercial products ( ATSDR, 2012 ; US EPA, 2006a )

. EPA was unable to identify any US sources that definitively stated the chemical is used in the production of
consumer pro ducts. A European risk assessment stated that the chemical is used as a solvent in the production of several products that may be used by consumers ( European Chemicals Bureau, 2002 )

.

Contaminant in Consumer Products. 1,4

- dioxane may be present as a contaminant in

consumer cosmetics/toiletries, household detergents, pharmaceuticals, foods, agricultural and veterinary products and ethylene glycol

- based antifreeze coolants. I t is formed as a byproduct

4 The manufacturer submitted a correction to EPA to revise the 2012 CDR to reflect that 1,4

- dioxane is not used for the categories ‘Paints and Coatings’ and ‘Laundry and Dishwashing Products’. The correction was received and is not yet indicated in the CDR public database

.Page 17 of 54

during th e manufacture of ethoxylated surfactants. M anufacture r s can remove most of the 1,4

- dioxane in consumer products through a vacuum stripping process ( ATSDR, 2012 ) , although the extent that this occurs is unknown

.Page 18 of 54

Table 2

- 3 : CDR Industrial and Consumer Use Data.

Manufacturing Site Parent

Company Industrial Use Data Consumer and Commercial Use Data

Sector Function

Category Industrial Use Percent of Production Volume Product

Category * Commercial or

Consumer Use Percent of

Production Volume Novolyte Perfo rmance Materials 111 West Irene Road Zachary, LA 70791 BASF All Other Basic Organic Chemical Manufacturing Processing

aids, not otherwise listed Use

- non

incorporative activities* CBI Paints and Coatings Commercial CBI

Laundry and Dishwashing Products Commercial CBI

Note: Use in non

- incorporative activities would include uses such as chemical processing aids or chemical manufacturing aids, where the chemic al is not intended to remain in or become part of the final product, or ancillary activities where a chemical is used a t a facility for purposes other than aiding chemical processing or manufacturing (e.g. degreasers or cleaners). Source: The public 2012 CDR Database; updated June 11, 2014 ( US EPA, 2012b )

. *A correction was received that is not yet indicated in the CDR public database

.Page 19 of 54



### 2.3 Fate and Transport

Environmental fate properties are summarized in Table 2

- 4

.
Based on available environmental fate data, 1,4

- dioxa ne is expected to volatilize readily from dry surfaces, reside in water and soil compartments if released to the environment, and have high persistence and low bioaccumulation potential in the environment. 1,4

- Dioxane is not readily biodegradable under nor mal environmental conditions.

1,4

- Dioxane is expected to volatilize from dry surfaces and dry soil due to its high vapor
pressure. It reacts with hydroxyl radicals (OH  ) in the atmosphere where the estimated atmospheric photooxidation half

- life of 1,4

- dioxane is 4.6 hours ( US EPA, 2013a ) . 1,4

- Dioxane is not expected to be susceptible to direct photolysis under environmental conditions since this compound lacks functional groups that absorb light at visible

- UV light wavelengths ( Lyman et al., 1982 ; NIH, 2006 )

. 1,4

- dioxane will not hydrolyze in water b ecause it does not have functional hydrolyzable groups ( ATSDR, 2012 )

.

Due to a high water solubility of > 8.00 × 10 2 g/L ( Yalkowsky and He, 2003 ) and a low Henry’s Law constant of 4.8 × 10 - 6 atm

- m 3 /mol at 25 °C ( Howard, 1990 ; US EPA, 20 09 )
, 1,4

- dioxane is expected to be only slightly volatile from water surfaces and moist soil. Once it enters the environment, 1,4

- dioxane is expected to have high mobility in soil based on its negligible K oc value of 0.4 ( US EPA, 2013a )

. 1,4

- dioxane is not expected to significantly sorb to suspended solids and sediment and
, therefore, may migrate rapid ly to surface waters and groundwater.

In a ready biodegradation test, following OECD Guideline 301 F (Manometric Respirometry Test), reported by the European Chemicals Agency (ECHA), 1,4

- dioxane was degraded less than 10 percent in 29 days ( ECHA, 2014a )

. In anothe r ready biodegradation test following OECD Guideline 310 (Headspace Test) 1,4

- dioxane was degraded less than 5 percent in 60 days ( ECHA, 2014b ) . 1,4

- dioxane is considered to be not readily biodegradable.

In a soil microcosm study which analyzed the potential for bacteria to degrade 1,4

- dioxane
, 1,4

- dioxane was not biodegraded during a 120 day period by i ndigenous bacteria. During the next 6 months, the bacteria removed about 60% of the added 1,4

- dioxane. The reason for the delayed biodegradation was not clear ( Kelley et al., 2001 )

. In a bioaccumulation test using the common carp ( Cyprinus carpio ) following OECD Test Guideline 305, measured bioconcentration factor (BCF) values of 0.3

- 0.7 at a concentration of 10 mg/L, and 0.2

- 0.6 at a concent ration of 1 mg/L were reported ( ECHA, 2014c )

. These values ind icate that bioaccumulation 1,4

- dioxane is low.

Using the environmental fate estimation model EPIS uite TM (Estimation Program Interface Suite for Microsoft Windows) v 4.11, a level III fugacity model with equal releases of 1,4

- dioxane toPage 20 of 54

air, water, soil, and sediment, estimates that 1 ,4

- dioxane will tend to partition mostly to soil (52.6%), and water (44.7%) ( US EPA, 2013a ) ( Table 2

- 4 ).

Table 2

- 4 : Environmental Fate Endpoints for 1,4

- Dioxane

. Endpoint Environmental Fate Data References Photodegradation Half

- life 4.579 hours

(estimated rate constant of 2.8 × 10 - 11 cm 3 /molec

- sec 1.5 × 10 6 hydroxyl radicals per cm 3
12

- hour day) ( US EPA, 2013a )

Hydrolysis Half

- life Does not undergo hydrolysis ( ATSDR, 2012 ) Biodegradation <10% in 29 days (OECD 301F)

<5% in 60 days (OECD 310) 0% after 120 days in soil microcosms; 60% after 300 days ( ECHA, 2014a ) ( ECHA, 2014b ) ( Kelley et al., 2001 )
Bioconcentration BCF = 0.2

– 0.6 (measured in carp at 1 mg/L)

BCF = 0.3

– 0.7 (measured in carp at 10 mg/L) ( ECHA, 2014c )

Log K oc 0.4 (estimated) ( US EPA, 2013a )

F ugacity (Level III Model) Air (%) Water (%) Soil (%) Sediment (%) 2.65

44.7 52.6 0.0868 (The input values for this estimation are the melting point, boiling point, vapor pressure, water solubility, Log K OW and Henry’s Law constant values provided in Table 2.1 above, and the following SMILES notation: O(CCOC1)C1) ( US EPA, 2013a )Page 21 of 54



### 2.4 Exposure s

T he exposure data identified and considered during problem formulation and used to construct the conceptual model and pose assessment questions is summarized . Use and exposure scenarios were selected for inclusion in the conceptual model by the identification of high volume uses that are known or likely to be associated with significant exposures.

Releases to the en vironment were assessed to determine potential pathway s of exposure for both human and ecological receptors. Exposures to w orkers, consumers and the general population were evaluated to determine the potential exposure to 1,4

- dioxane during manufacturing, formulation and use of products . E nvironmental exposure of the general population to 1,4

- dioxane in air or water was also considered

.

2.4.1 Releases to the Environment

Environmental releases of 1,4

- dioxane to air and water may contribute to ecological and
gen eral population exposures. The potential for release of 1,4

- dioxane to air is high due to the high vapor pressure of 1,4

- dioxane and disposal through incineration

. Industrial and commercial use of 1,4

- dioxane and presence in consumer products suggest releases to water are possible. Readily available sources of information for environmental releases that may lead to exposures were reviewed including the EPA Toxic Release Inventory (TRI) database ( US EPA, 2012c )

.
An analysis of TRI data from 1988 to 2007 indicates that total on

- site releases of 1,4

- dioxane

are generally decreasing. During this period, the high was 1,234,968 pounds in 1993 and the low was 182,338 po unds in 2007; 69% of the 2007 total releases fro m 45 facilities were to air ( ATSDR, 2012 )

. Data from the most recent TRI indicate that 82% of the total on

- and off

- site releases of 106,300 pounds from 39 sites (including the manufacturing site) were to air (on

- site fugitive and point sources) and 18% were to surface water. An additional 1,035,300 pounds

were reported released from two additional si tes that primarily inject 1,4

- dioxane in underground w ells (on

- site and off

- site) or sen d to waste brokers ( US EPA, 2012c ) . Releases to these wells and to waste brokers are not usually a concern for human exposures. F acilities that release less than 25,000 pounds are not required to report data to the TRI.

The EPISuite TM model ( Table 2

- 4 ) indicates that followi ng release, 1,4

- dioxane will partition predominantly to water and moist soil. Likely exposure pathways are by atmospheric deposition and runoff into surface water and leaching into groundwater.

2.4.2 Presence in the EnvironmentPage 22 of 54

EPA/OPPT reviewed available information on the presence of 1,4

- dioxane in the environment from the 2002 EU Risk Assessment Report (RAR) , a leachate study from two landfills, a groundwater plume study and two WWTP studies.

The EU RAR included predicted environmental concentrations (PECs) for wastewater effluent and surface water and a limited number of measured data of 1,4

- dioxane in su rface water, drinking water, wastewater effluent and leachate from the vicinity of landfills ( European Chemicals Bureau, 2002 ) . Site

- specific and generic location emission data were used to generate estimated regional release values to surface water and WWTPs and develop the PECs. The PECs in surface water were based on estimated regional releases to water of 434 kg/d and the estimated regional release via WWTP was 304 kg/d ( European Chemicals Bureau, 2002 )

. PECs of 1,4

- dioxane in wastewater effluent ranged fro m 0.002

– 183 mg/L based on life cycle stages or scenarios. PECs in surface water during an emission episode ranged from 0.001 mg/L (contaminated alkyl eth oxy sulphates) to 18.3 mg/L ( processing pharmaceuticals and pesticides ) ( European Chemicals Bureau, 2002 )

.

In the EU RAR , surface water data in a Dutch study were compared to the predicted regional environmental concentration of 1.3  g/L and was within the study values of 1

- 10  g/L. The measured data for th e WWTP effluent from unintentional release from a PET plan t was much higher (100 mg/L) than the PEC of 0.01

– 6.9 mg/L for site

- specific emission data for various unint entional 1,4

- dioxane releases. However, t he EU RAR noted that the source of the measured 100 mg/L value used may be unreliable ( European Chemicals Bureau, 2002 )

.
The primary method of disposal of 1,4

- dioxane is by incineration ( ATSDR, 2012 ) . In a study, that investigated 1,4

- dioxane in landfill leachate, extremely high levels of 1,4

- dioxane (89 and 340 mg/L) were detected in the leachate from two landfill sites. Analysis of leachate and measurement of 1,4

- dioxane in incineration residues suggest that the most likely source of 1,4

- dioxane in the leachate is the fly ash produced by municipal solid waste incinerators ( Fujiwara et al., 2008 )

.
Groundwater beneath the city of Ann Arbor , Michigan is currently contaminate d with 1,4

- dioxane after it was used as an industrial solvent and the contaminated waste water was stored in unlined wastewater lagoons between 1976 and 1986 ( City of Ann Arbor, 2015 ) . Since then, the chemical has seeped through the soil and entered the groundwater in the Ann Arbor area. Concentrations up to 7,000 ppb have been detected in the plume at the source. The maximum concentration of 1,4

- dioxane detected at an off

- site monitoring well near the center of the plume was 3,788 ppb ( Pall Corporation, 2004 ) . In 2004 , c oncentrations of 1,4

- dioxane in influent and effluent were measured in a WWTP in Ann Arbor, MI. In February, April and June, raw wastewater influent concentrations were 3, 2 and 3  g/L, respectively. Treated effluent concentrations were 3, 1 and 3 for thos e same months ( Skadsen, 2004 ) . The similar influent and effluent values suggest that 1,4

- dioxane is not readily remove d and passes through a municipal WWTP.Page 23 of 54

Samples of waste water effluent were collected from 40 municipal WWTPs that receive predominantly domest ic wastewater from households. Sampling took place in 2010 and included WWTPs at select sites in 15 states. Of the WWTPs effluents samples, two had 1,4

- dioxane concentrations below the LOQ (<0.30  g/L) and 38 samples had concentrations between 0.30 and 3.30  g/L ( Simonich et al., 2013 )

.

2.4.3 Occupational Exposure

Occupational exposure data from three sources were reviewed : the 2002 EU RAR , the OSHA Chemical Exposure Health Data database , and a data set provided by an American Chemistry Cou ncil (ACC) member company.

M anufacturing site s produce 1,4

- dioxane in liquid form at 90 percent concentration or higher. Workers may be exposed by inhalation and skin contact when they work with 1,4

- dioxane. The high vapor pressure of 1,4

- dioxane causes a high potential for air releases and associated worker inhalation exposure. Dermal exposure may occur, but due to a low rate of absorption through th e skin and rapid volatilization, inhalation is considered the predominant route of
exposure

.
Occupational exposure limits can af fect the handling and processing of chemical s , thereby reducing the potential for exposures. The US has several regulatory and non

- regulatory exposure limits for 1,4

- dioxane ( ACGIH, 2009 ) : an Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (PEL) of 100 ppm 8

- hour time

- weighted average (TWA) (360 mg/m 3 ) with a skin notation, a National Institute of Occupational Safety and Health (NIOSH) Reco mmended Exposure Limit (REL) of 1 ppm (3.6 mg/m 3 ) as a 30 minute ceiling, and an American Conference of Government Industrial Hygienists (ACGIH) Threshold Limit Value (TLV) of 20 ppm TWA (72 mg/m 3 ).

P ublic CDR information ( US EPA, 2012c ) indicates there is one domestic manufacturing site, 25 to 99 industrial processing sites and two commercial/ consumer product categories (Paints and Coatings and Laundry and Dishwashing Products) for this chemical 5

. Inform ation on c urr ent domestic processing and use of 1,4

- dioxane that may result in exposures is limited

. 1,4

- dioxane has been potentially formulated into specialized products for industries in Europe with no expected consumer uses. Also, some processes to make other chemicals produce 1,4

- dioxane as a reaction byproduct (e.g., ethoxylation reactions), and these chemicals have a variety of uses that may result in worker and consumer exposures.

5 The manufacturer submitted a correction to EPA to revise the 2012 CDR to reflect that 1,4

- dioxane is not used for the categories ‘Paints and Coatings’ and ‘Laundry and Dishwashing Products’. The correction was received and is not yet ind icated in public database

.Page 24 of 54

In the US, l imited w orker inhalation monitoring data for this chemica l were found in the OSHA Chemical Exposure Health Data database ( OSHA, 2014 ) . During the most recent 15 year period (1997

- 2011), 21 samples were taken from 6 sites, with 2 detects of 0.21 and 0.22 ppm and 19

non

- detects. Worker monitoring data specific to an American Chemistry Council (ACC) member company facility where 1,4

- dioxane is produced as a byproduct in its manufacturing process were collected from 2001 to 2003 ( Franz, 2014 ) . All of the 21 samples taken at this facility were below analytical detection limits, which ranged from 0.044 to 0.9 ppm (0.16 to 3.24 mg/m 3 )

. The two sets of data are too limited to consider representative of potential exposures t hat may occur throughout the US ( Appendix C: Occupational Exposure Data )

.
Estimates of worker exposure in Europe are provid ed in the EU RAR ( European Chemicals Bureau, 2002 ) for 1,4

- dioxane. I nhalation concentrat ions and dermal doses for worker exposures in five “Worker Use Activity” scenarios ( Table 2

- 5 ) were estimated : production, formulation and three end uses (cleaning age nts in industries such as metal fabrication; paints and varnishes in the production of precision and optical instruments, watches and clocks; and lab solvents). All of these scenarios were relevant primarily to industrial and laboratory facilities.

Table 2

- 5 : Exposure Concentrations for Occupational Scenarios in European Industrial and Laboratory Facilities

. Worker Use Activity Reasonable Worst

- case inhalation concentration (mg/m 3 , TWA) Typical inhalation concentration (mg/m 3 , TWA) Manufacturing 10 (measured) 0.2 (measured) Processing/ formulating 180 (modeled) 40 (modeled) Use of cleaning agent 50 (measured) 15 (measured) Use of paint 11 (modeled) 2 (modeled) Use of solvent in lab 25 (calc. from measured values) 5 (measured) Table Note: “It is not clear whether the chemical is still used in cleaning agents.” Source: Table 4

- 4 in ( European Chemicals Bureau, 2002 )

. Comparing the concentration s of 1,4

- dioxane estimated for worker inhalation in Europe ( Table 2

- 5 ) to US limits and recommended action levels, exposures did not exceed the OSHA Pe rmissible Exposure Limit (PEL), but typically exceeded the NIOSH Recommended Exposure Limit (REL). EPA/OPPT could not determine whether the worker exposures estimated in the EU assessment are similar to those in the US.

The European report did not estima te worker exposures for processes that produce 1,4

- dioxane as a reaction byproduct (e.g., ethoxylation reactions). C oncentrations of 1,4

- dioxane as a contaminant in detergents and paints are expected to be lower than the estimated concentrations of 1,4

- dioxane in processed formulations

. Formulations typically contain 10 weight percent or higher handled by workers in the assessed European scenarios. Worker exposures to commercial products (such as detergents and paints) containing 1,4

- dioxane as aPage 25 of 54

co ntaminant could therefore be ord ers of magnitude below the EU RAR estimated exposure concentrations.

No information was found regarding the current total number of workers exposed to 1,4

- dioxane . Historical estimates from the 1970s and 1980s indicate that the number of workers potentially exposed to 1,4

- dioxane could have be en u p t o 466,000 individuals ( ATSDR, 2012 ) . Of those workers, significant numbers were estimated to have been exposed as a result of the use of 1,4

- dioxane as a stabilizer in TCA. While there is no data on current worker populations, the numbers are expected to be much lower assuming production of 1,4

- dioxane has been reduced, p articularly for use as a stabilizer in 1,1,1

- trichloroethane ( TCA )

.
In conclusion, workers in the US may be expos ed to 1,4

- dioxane

. Several very limited worker monitoring data sets for US workers showed exposures to be below both the OSHA PEL and the NIOSH REL, but these data are very limited and may not b e representative of exposures in the US. Worker exposure estimates in the EU could be a reasonable starting point for assessing exposures in the US. I n order to better characterize worker exposure s to 1,4

- dioxane in the US
, information on current uses and volumes, processes used during production/formulation, worker activities and measurements of exposure levels are needed

.

2.4.4 General Population Exposure

G eneral population exposure s were identified and considered during problem formulation. A review of available data and assessments for 1,4

- dioxane reveal ed that potential general population exposure can occur from ingesting contaminated drinking water and inhal ing 1,4

- dioxane in the air. Exposures to 1,4

- dioxane in food and cosmetics are outside the scope of TSCA, have been addressed by other organizations such as FDA and are not addressed in this
assessment

.
Exposure in Air Air releases of 1,4

- dioxane have decreased notably due to the ban of TCA according to historical data . The TRI data indicate that air is the media with the greatest releases ( ATSDR, 2012 ; US EPA, 2012c )

. TRI data is summarized in Se ction 2.4.1 Releases to the Environment

.
Exposure in Drinking Water Recent actions from the State of California ( CSWRCB, 2014 ) have labeled 1,4

- dioxane as an emerging contaminant because of its increas ed presence in drinking water. The California Department of Public Health’s Drinking Water Program measured 1,4

- dioxane levels in drinking water systems from 2000 to 2013. The program reported a mean concentration of 0.0042 mg/L; a median of 0.003 mg/L; and maximum concentration of 0.053 mg/L in the 2,592 samples taken.Page 26 of 54

H igh concentrations of 1,4

- dioxane have been found in run off ditches ar ound Superfund sites and nearby drinking water wells have been contaminated at levels above concern for health effects ( ATSDR, 2012 )

.

EPA /O W ’s three year monitoring program ( i.e. UCMR) of public water systems (PWS) test s for 1,4

- dioxane and other chemicals in finished drinking water ( US EPA, 2014e ) . Samples are collected at entry points to the distribution system (i.e.
, t he point at which water is discharged into the distribution system from a well, storage tank, pressure tank or water treatment plant). Source water (i.e.
, ambient surface or ground water) is not measured as part of the UCMR.

Monitoring data from PWSs during the first two years of the UCMR program as of January 2015 are summarized in Table 2

- 6

. The results include 243 PWSs representing 708 samples with results greater than the 10 - 6 cancer reference concentration (0.35  g/l ) and no PWSs with detections above the 10 - 4 cancer reference concentration level (35 ppb)

. It is unknown whether additional monitoring data will result in higher occurrenc e or detection levels of 1,4

- dioxane in PWSs. Since 1,4

- dioxane is being monitored through December 2015
, d ecisions as to whether or not to regulate the contaminant in drinking water will be considered as part of the EPA ’s Regulatory Determination process ( US EPA, 2014e )

. The reference concentrations used for 1, 4

- dioxane are based on publically

- available health information found in the 2012 Drinking Water Standards and Health Advisory ( US EPA, 2012a ) and range from 0.35 to 35  g/l, based on cancer risk of 10 - 6 to 10 - 4 , respectively

. The draft reference concentration does not represent an “action level”; EPA requires no particular action based simply on the f act that UCMR monitoring results exceed draft reference concentrations, nor should the draft reference concentration be interpreted as any indication of EPA’s intent to establish a future drinking water regulation for the contaminant at this or any other l evel ( US EPA, 2014e )

.

Table 2

- 6 : Preliminary Data from the EPA UCMR 3 (January 2015)

.

C on ta m i n a nt M R L 1 Refe r e n ce C on c. 1 ,2 T o ta l #

of r es u l ts # of

r es u l t s ≥ M RL # of

r es u l t s > Ref. C on c. 2 % of t o ta l

r es u l t s > Ref. C on c. 2 T o ta l

nu m b e r of P W S s
w i t h
r es u l t s # o f

P W S s
w i t h
r es u l t s ≥ M RL # of P W S s

w i t h
r es u l t s > Ref. C on c. 2 % of P W S s

w i t h r es u l t s > Ref. C on c. 2

1,4

- dioxane 0.07 0.35 / 35 22 , 611 61 3 2 708 / 0 3. 1 % / 0% 587 3 727 243 / 0 6.8% / 0%

( http://water.epa.gov/lawsregs/rulesregs/sdwa/ucmr/upload/epa815s15001.pdf
1 Measured in μg/L (ppb)
2 Where two reference concentrations are listed, the first number is associated with a 10 - 6 cancer risk; the second number a 10 - 4 cancer risk. Where two results are presented the first number is associated with the first reference concentration; the second number is associated with the second reference concentration.Page 27 of 54

2.4.5 Consumer Exposure

The primary route of consumer exposure to 1,4

- dioxane is by inhalation and dermal contact with contaminated consumer products containing ethoxylated surfactants such as personal care products, soaps and detergents. Limited data on c oncentrations in consumer products exist

. Currently, manufacturers may voluntarily 1) minimize the formation of the 1,4

- dioxane as by

- product during manufacture of alkyl ethoxy sulfates (AES), or 2) remove 1,4

- dioxane by stripping the AES paste before formulation of ethoxylated surfactants in to consumer cosmetics and household products . The extent to which manufacturers use these practices is uncertain.

Cosmetics and personal care products are regulated by FDA. FDA h as estimated c onsumer exposure to 1,4

- dioxane to be low ( US FDA, 2007 )

. FDA reported that levels of 1,4

- dioxane present in products such as shampoo and body wash do not pose a significant risk to consumers since products do not remain in contact with the skin for a long period of time ( US FDA, 2007 )

. FDA do es not consider concentrations of 1,4

- dioxane measured in cosmetics and toiletries to be a risk of concern ( ATSDR, 2012 ) . These uses are outside the jurisdiction of TSCA regulatory authority.

EPA/OPPT reviewed l imited data on measured concentrat ions of 1,4

- dioxane in products . Levels of 1,4

- dioxane in cosmetics are reported from two sources as 6

- 34 ppm (Black, 2001) and non

detectable to 487 ppm ( European Chemicals Bureau, 2002 ) . When u sed as a chemical intermediate, 1,4

- dioxane concentrations are 100

- 380 ppm in pharmaceuticals and 1.0 to 2.8% w/w% in household adhesives ( ATSDR, 2012 ) . Unintentional contamination levels of 1,4

- dioxane in products are < 10 ppm in food ( European Chemicals Bureau, 2002 ) , 6

- 160 ppm in household detergents ( ATSDR, 2012 ) and 0.1

– 22 ppm in antifreeze and deicing products ( European Chemicals Bureau, 2002 )

. An analysis of consumer products by the Campaign for Safe C osmetics found 1,4

- dioxane in 32 out of 48 personal care products and cosmetics tested (67%) at levels ranging from 0.27 to 35 ppm. The Organic Consumers Association tested 100 organic and natural consumer products and found detectable levels of 1,4

- dioxane in 47 products. In a study of household products (soaps, shampoos, cleaners and detergents) in Japan, 1,4

- dioxane was detected in 40 out of 51 products at concentrations from 0.05 to 33 mg/kg with a mean of 2.7 mg/kg ( Tanabe and Kawata, 2008 )

.
The European r isk a ssessment evaluated risk of exposure to several consumer products: shampoos, baby lotion and hand dishwashing liquid via dermal and inhalation routes using ConsExpo, a well

- documented exposure model for substances from consumer products ( European Chemicals Bureau, 2002 )

. T he worst case scenario yielded a combined total internal dose of 3.3 μg/kg

- bw/day and the “very worst case” combined total internal dose was 10 μg/kg

- bw/day ( European Chemicals Bureau, 2002 )

. The margin s of safety f or consumer inha lation and dermal exposure scenarios for the three product categories ranged from greater than 1000 to greater than 10,000 using health benchmarks available at the time.

The Canadian risk assessment presented aggregate exposure estimate s for various age g roups including infants, children and adults ( Environment Canada and Health Canada, 2010 ) . AdultPage 28 of 54

women were considered the highest exposed demographic group due to the use of cosmetics and well as other consumer products. The estimated aggregate intake of 1,4

- dioxane for daily use of hair conditioner, hair shampoo , skin moisturizer (body cream) and bo dy wash was 1.2 μg/kg

- bw per day. The margins of safety for daily intake (dermal and inhalation) for aggregate exposure of the general population and consumers ranged from 7620 to 50,000 using the same point of departure (Kociba et al., 1974) as used to de rive the oral IRIS RfD.

EPA/OPPT concludes that e xposure to consumers can result from the use of soaps and detergents and other products that contain 1,4

- dioxane as a contaminant

. Adult women who

use multiple cosmetics and cleaning products are likely th e most exposed population as determined in the Canada assessment

. The EU RAR and Canada separately assessed aggregate risks from exposure to several consumer products and found no risk of concern . However, the assumptions used in those assessments may diff er from EPA risk assessment guidelines
, and EPA IRIS recently published an updated review of health benchmarks for non

- cancer and cancer endpoints that includes new studies not considered in the previous assessments.



### 2.5 Hazard Endpoints

2.5.1 Environmental Hazard

The available e cotoxicity studies for 1,4

- di ox ane on fish, aquatic invertebrates and aquatic plants are summarized in Appendix D . There are no studies for 1,4

- dioxane on sediment, soil or terrestrial organisms.

The hazard of 1,4

- di ox ane to aquatic organisms is low

. The hazard of 1,4

- dioxane is expected to be low for soil organisms due to its high potential to volatilize from soil surfaces and low for sediment

- dwelling organisms due to its low adsorption potential to sediment.

2.5.2 Human Health Hazard

A detailed summary of human health studies is in Appendix E

- 1 and additional information can be found in the EPA IRIS Toxicological Review of 1,4

- Dioxane (with Inhalation Update) available
at: http://www.epa.gov/IRIS/toxreviews/0326tr.pdf

.
Several national and international organizations have evaluated the human health hazard of 1,4

- dioxane . Previous assessments were review ed to identify potential hazard concerns of 1,4

- dioxane including a 2013 IRIS review ( US EPA, 2013b ) , a 2012 ATSDR Toxicological Profile ( ATSDR, 2012 )
, a Canadian screening assessment ( Environment Canada and Health Canada, 2010 ) and the EU RAR ( European Chemicals Bureau, 2002 )

.
Moderate to high hazard concerns for repeated exposures are based on subchronic and chronic oral and inhalation studies. In subchronic studies, the prim ary target organs are the liver,Page 29 of 54

kidney and nasal/respiratory epithelium. Chronic studies have reported an apparent progression to tumor formation at these sites that appears to be independent of genotoxicity

.
Physiologically based pharmacokinetic models (PBPK) models have been developed for 1,4

- dioxane in rats , mice, humans and lactating women ( US EP A, 2013b )

. Animal studies indicate 1,4

- dioxane is readily absorbed via oral and inhalation exposures, with less absorption through the skin ( ATSD R, 2012 ) . No data are available on the distribution of 1,4 dioxane in humans, and no data on distribution are available in animals via oral or inhalation routes. Metabolism of 1,4

- dioxane in humans and experimental animals is extensive. Rats were shown to metabolize inhaled 1,4

- dioxane to β

- hydroxyethoxy acetic acid (HEAA ). Elimination of 1,4

- dioxane in humans and rats is via the urine in the form of HEAA.

Mortality was observed in multiple acute high

- dose studies in rats, mice and rabbits. The acute

o ral, dermal and inhalation toxicity of 1,4

- dioxane is low in rats, mice and rabbits

. Repeated

dose toxicity studies in rats via oral administration with 1,4

- dioxane a t mid

- and high

- dose, showed variable degrees of kidney and liver changes and mortality. L iver and nasal carcinomas were observed in rats via the inhalation route.

Delayed ossification of the sternebrae and reduced fetal body weights were observed in a prenatal developmental t oxicity study with 1,4

- dioxane. No reproductive toxicity studies hav e been performed with 1,4

- dioxane; however, no histopathological changes were reported in the reproductive organs of male and female rats/mice exposed in s ubchronic and chronic studies. The high dose at which developmental effects occurred suggests a low h azard for developmental and reproductive toxicity.

The genotoxic potential of 1,4

- dioxane has been evaluated using in vitro and in vivo assay systems. The majority of in vitro assays with 1,4

- dioxane were nongenotoxic. Fifty

- percent of in vivo studies with 1,4

- dioxane were positive. EPA ( US EPA, 2013b ) concluded that 1,4

- dioxane is nongenotoxic o r weakly genotoxic based on the IRIS review.

No treatment

- related effects were observed in a single dose dermal irritation assay in rats. In a 90

- day inhalation study, no gross or microscopic alterations were reported in the skin of rats. However, this st udy was conducted via inhalation and does not provide an adequate representation of dermal toxicity.

Evidence of carcinogenicity in animals (l iver and nasal tumors, mesotheliomas of the peritoneum in male rats and an increase in mammary gland adenomas i n female rats) indicates that 1,4

- d ioxane is “likely to be carcinogenic to humans” ( US EPA, 2013b )

. A can cer slope factor (CSF) of 0.1 ( mg/kg/day ) - 1 was derived from the tumor incidence data for nasal squamous cell carcinomas in mice and gall bladder carcinomas in guinea pigs. A new two

- year inhalation bioassay in rats was used to calculate an inhalation unit risk (IUR) of 5 x 10 - 6 (μg/m 3 ) - 1 ( US EPA, 2013b )

.Page 30 of 54



### 2.6 Results of Problem Formulation
The results of p roblem f ormulation are a conceptual model
, key assessment questions and an analysis plan for human health ( US EPA, 2014b )

. A c onceptual m odel was not developed for environmental health due to the low ecotoxicity hazard values reported from standard acute and chronic ecological toxicity tests.

2.6.1 Conceptual Model

The following conceptual model ( Figure 2

- 2 ) illustrates the sources and potential pathways (arrows) of 1,4

- dioxane from chemical manufacture and formulation , releases to the environment and potentia l exposure pathways for human ( workers, consumer and general population) receptors. The blue solid and dotted blue lines in the conceptual model represent pathways from potential source s , and the red solid and dotted lines represent potential exposure path ways via inhalation or ingestion for human receptors

. Dermal exposures are not addressed due to a low rate of absorption, high volatilization and lack of dermal toxicity studies. Potential human health effects include cancer (progression of tumor formation ) and noncancer outcomes (liver, kidney and nasal effects) in workers, consumers and the general population.

The source

- exposure

- receptor pathways, labeled numerically in the conceptual model, are described as follows:

1. W orkers may be potentially exposed from inhalation exposures during manufacturing and formulation of 1,4

- dioxane or in industrial or laboratory facilities where 1,4

- dioxane is used

.

2

. W orkers and consumers may be p otentially exposed by inhalation during the use of products that c ontain 1,4

- dioxane as a contaminant

.

3

. Inhalation exposures may occur to the general population as a result of emissions from manufacturing/formulating /use facilities, as well as incineration of waste streams/products.

4. Oral exposures to the general population may occur from drinking contaminat ed
water

. 1,4

- D ioxane in surface water or ground water may travel through public drinking water treatment plants (DWTPs) and private wells to the “tap”. The source contributions to drinking water are uncertain and may originate from wastewater effluent, leaching from landfills and disposal sites to groundwater and surface water.Page 31 of 54

Figure 2

- 2 : Conceptual Mo del of Potential Exposure Pathways for 1,4

- Dioxane

. Solid blue lines represent potential source pathways; solid red lines represent exposure pathways to receptors; dotted blue lines indicate pathways with limited data to assess.

Four key assessment questions were developed from the Conceptual Model :

1. Are there risks to worker s exposed during manufacturing and formulation of 1,4

- dioxane or in industrial or laboratory facilities where 1,4

- dioxane is used?

A 2002 European assessment fo und potential risk to workers for occupational exposures via the dermal and inhalation routes during product formulation and the use of 1,4

- dioxane as a cleaning agent. Comparing the estimates of worker inhalation in Europe to US limits and recommended act ion levels, exposures did not exceed the OSHA Permissible Exposure Limit (PEL), but typically exceeded the NIOSH Recommended Exposure Limit (REL). Exceeding the NIOSH RE L may indicate potential exposure concerns

. The few US data on worker exposure were bel ow the NIOSH REL. However, EPA’s recently updated IRIS cancer and non

- cancer benchmarks for human health suggest that human health risks should be reassessed.

2. Are there risks to w orkers and consumers potentially exposed by inhalation during the use of products that contain 1,4

- dioxane as a contaminant?

Workers and consumers may be exposed to 1,4

- dioxane present as a contaminant in products such as personal care products, paints, adhesives, varnish es , cleaners and detergent s . Previous risk assessments in Canada and Europe concluded that levels of contamination do not pose concerns for human health. However, the assumptions used in those assessments may differ from E PA risk assessment guidelines. EPA’s recently updated IRIS benchmarks f or non

- cancerPage 32 of 54

and cancer human health endpoints
, including new studies
, were not considered in the previous assessments. EPA/OPPT should reassess risks to workers and consumers from products. While personal care products are regulated by the FDA, uses in p aints, adhesives, varnish es , cleaners and detergent s fall under TSCA authority.

3

. A re air emissions of 1,4

- dioxane a potential risk to the general population from inhalation exposure ?

EPA/OPPT considered the exposure of the general population to ambien t air levels of 1,4

- dioxane

. Minimal data on 1,4

- dioxane uses and releases to the environment exist for estimating the ambient levels of 1,4

- dioxane in air and recent monitoring data is unavailable

. TRI data ( US EPA, 2012c ) indicate that there are 39 sites reporting the release of 106,300 pounds of 1,4

- dioxane to on

- and off

- site releases with 82% of these air releases to on site fugitive and point sources and 18% to surface water. There was an additional 1 ,035,300 pounds from two sites with almost all going to underground injection wells (on

- site and off

- site) and waste brokers.

Since phasing out of the use of 1,4

- dioxane as a stabilizer in chlorinated solvents except for select uses, a ir releases of 1,4

- dioxane have decreased as can be seen in the TRI data (Section 2.4.1 )

. Air monitoring data from urban areas in the 1980s and 1990s showed significant decreases in 1 ,4

- dioxane over the period covering the phase out. Since the 1990’s, the reduction seems to have leveled off. The latest TRI data indicate that air releases continue to

occur

.
During problem formulation, EPA/OPPT considered that 1,4

- dioxane is: 1) regulated under the CAA as a hazardous air pollutant ( US EPA, 2000 ) ; 2) photooxidized in the environment with a t 1/2 of 1

- 3 days ; and, 3) his torical levels of 1,4

- dioxane range from 0.0001 to 0.0004 mg/m 3 ( i.e. , 0.1 μg/m 3 to 0.4 μg/m 3 ) ( ATSDR, 2012 )

. Canada assessed the exposure of the general population to 1,4

- dioxane in air and concluded that there is no risk of concern ( Environment Canada and Health Canada, 2010 )

. Compared to the IRIS R eference C oncentration (RfC ) ( US EPA, 2013b ) for noncancer effects ( 0.03 mg/m 3 ), the historical levels are 75 to 300 times lower than the RfC

. Calcula tion of lifetime cancer risk using the IRIS IUR ( 5 × 10 - 6 (μg/m 3 ) - 1 ) ( US EPA, 2013b ) indicates that risks associated with historical 1,4

- dioxane levels range from 5 × 10 - 7 to 2 × 10 - 6

, which are below EPA’s target risk range of 1 × 10 - 6 to 1 × 10 - 4

.

4

. Are there risks to the general population from drinking water contaminated with 1,4

- dioxane ?

Data being generated by EPA’s OW show that the general population may be exposed to 1,4

- dioxane from contamination of finished drinking water . Groundwater may also be a source of general population exposures espe cially around Superfund sites. However, base d on the limited data, it may be premature for EPA/ OPPT to conduct a TSCA risk assessment of the drinking water pathway because there is too much uncertainty to adequately characterize source contributions of 1,4

- dioxane in drinking water from TSCA uses. E PA’s OW is currently monitoring for 1,4

- dioxane as part of the UCMR 3 monitoring program until December 2015

.Page 33 of 54

EPA will determine whether or not regulatory action is needed as part of the EPA ’s Regulatory Determination process.

2.6.2 Analysis Plan

Based on Pro blem Formulation, EPA/OPPT plans to us e available data to evaluate:

1. Potential occupational risks of exposure to 1,4

- dioxane during manufacturing and formulation of 1,4

- dioxane or in industrial or laboratory facilities where 1,4

- dioxane is used

.

2. Potential risks to w orkers and consumers exposed by inhalation during the use of products that contain 1,4

- dioxane as a contaminant.

For the exposure assessment, EPA/OPPT plans to use the following data and information to estimate worker exposures:

 Physic o

- chemical data on 1,4

- dioxane

 Production volume and use information (non

- confidential )

 Data on concentrations of 1,4

- dioxane in commercial products from published literature or provided by industry or consumer groups

 Data and information on production , f ormulation and use processes

 Data from the OSHA Chemical Exposure Health Data database or provided by industry

 Measured and modeled data and information from exposure scenarios considered in the Canadian and European assessment s.
For the hazard assessment, EPA/OPPT plans to carefully review the existing human health benchmarks es tablished by OSHA, NIOSH, ATSDR and EPA IRIS (Appendix B). EPA/OPPT will select the relevant benchmarks according to the relevant route of exposure. The ex posure estimates will be corrected for expected duration and frequency in agreement with the hazard
assessment.

For the risk characterization, EPA/OPPT will compare measured or estimated exposures to the selected hazard benchmarks and calculate cancer ris k estimates and non

- cancer margins of
exposure for workers and consumers exposed to 1,4

- dioxane through inhalation.

Given the limited amount of exposure data identified during problem formulation, EPA/OPPT will search for additional data and information on current uses and production volumes, processes used during production/formulation, worker activities
, concentrations in products and measurements of exposure levels.

Following review of comments and consideration of any additional data or information E PA/OPPT may receive, EPA/OPPT plans to publish a final assessment for 1,4

- dioxane.Page 34 of 54

2.6.3 Uncertainties and Data Gaps

The industrial and commercial use data as reported in the 2012 CDR database indicate n o current consumer uses ( US EPA, 2012b )

. The 2012 CDR does n ot give a complete picture of all uses because only manufacturers of more than 25,000 pounds of a chemical at a single site are required to report. Downstream industrial, consumer and commercial use data are reported only if they manufactured more than 100 ,000 pounds of a chemical during a particular year

. Processing and use is often not under the control of the manufacturers and they may have incomplete knowledge of these activities ( US EPA, 2014a ) . As a result of these factors, the processing and use information in the CDR public database presents only a limited picture of the actual processing and use situation in the United States ( US EPA, 2014a )

. Rece nt production volume and use data are claimed confidential by the manufacturer. EPA was unable to identify any US sources that definitively stated the chemical is used in the production of consumer products
, and therefore assumes there are no current consu mer uses

. As a contaminant, data on the concentrations of 1,4

- dioxane in consumer products are limited.

Data to understand the sources and pathways by which 1,4

- dioxane enters the environment are limited. The total actual releases from facilities that formulate or use 1,4

- dioxane have some uncertainties. For example, these releases may be higher than the total reported since facilities that release less than 25,000 pounds are not required to report data to the TRI. Legacy contamination, wastewater efflu ent and non

- point sources may also contribute to releases of 1,4

- dioxane in to the environment. Recent ambient air data are needed to better understand
current w orker exposures

.

E PA/ OPPT is uncertain whether worker exposures to 1,4

- dioxane in the US may be similar to those estimated in the EU RAR ( European Chemicals Bureau, 2002 )

. EPA/ OPPT is also uncertain whether the limited 1,4

- dioxane inhalation monitoring data for US workers are represent ative of occupat ional exposures in the US. Also, the historical total numbers of workers exposed to 1,4

- dioxane is expected to be much higher than the current total, which is unknown. Information on current uses and volumes, processes used during production/formulation,

w orker activities and measurements of exposure levels are not available. The extent to which manufacturers use processes to reduce the contamination of 1,4

- dioxane in products is unknown.

In the human health hazard assessment, EPA IRIS noted uncertainties in the development of the c ancer r isk values including the use of low

- dose extrapolation, dose metric, cross

- species scaling, alternative bioassays, species/gender combination, huma n relevance to mouse tumor data and human population variability in metabol ism and response/sensitive subpopulations. There is a data gap in human health hazard since no multigeneration reproductive toxicity studies are available for 1,4

- dioxane.Page 35 of 54



## REFERENCES

ACGIH. 2009. Guide to Occupational Exposure Values

. ATSDR (Agency for Toxicological Substances and Disease Registry). 2012. Toxicological Profile for 1,4

- Dioxane . U.S. Department of Health and Human Services, Atlanta, GA. http://www. atsdr.cdc.gov/toxprofiles/tp.asp?id=955&tid=199

. CA EPA OEHHA (State of California Environmental Protection Agency Office of Environmental Health Hazard Assessment). 2007. OEHHA Proposition 65 in Plain Language! http://oehha.ca.gov/prop65/background/p65plain.html (accessed on July 29, 2014).

CA EPA OEHHA (State of California Environmental Protection Agency Office of Environmental Health Hazard Assessment). 2014. Proposition 65 Revised Chemi cal List

. http://oehha.ca.gov/prop65/prop65_list/files/P65single050214.pdf (accessed on July 29, 2014).

City of Ann Arbor, M. 2015. 1,4

- Dioxane and Pall Life Sciences/Gelman Sc iences Site . Systems Planning. http://www.a2gov.org/departments/systems

planning/Sustainability/pls/Pages/pls.aspx (Jan. 28, 2015).

CSWRCB (California State Water Resources Control Board). 2014. 1,4

- Dioxane

. http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/14

- dioxane.shtml

. ECHA (European Chemic als Agency). 2014a. 1,4

- Dioxane

- Exp. Key Biodegradation in Water: Screening Test.001

. http://apps.echa.europa.eu/registered/data/dossiers/DISS

9d865c9c

- 7196

- 7016

- e044

- 00144f67d29/AGGR

- a576778b

- e754

- 48ef

- 9cf1

- 0cabcad496ad_DISS

- 9d865c9c

- 7196

- 7016

- e044

- 00144f67d249.html #AGGR

- a576778b

e754

- 48ef

- 9cf1

- 0cabcad496ad (Accessed on November 5th, 2014).

ECHA (European Chemicals Agency). 2014b. 1,4

- Dioxane

- Other Ns Biodegradation in Water: Screening Test.002. http://apps.echa.europa.eu/registered/data/dossiers/DISS

9d865c9c

- 7196

- 7016

- e044

- 0 0144f67d249/AGGR

- 72da2b15

- 4e90

- 4bd9098c8

- ed8c84ad4c7_DISS

- 9d865c9c

- 7196

- 7016

- e044

- 00144f67d249.html#AGGR

- 72da2b15

- 4e90

- 4bd9

- 98c8

- ed8c84ad4fc7 (November 5th, 2014).

ECHA (European Chemicals Agency). 2014c. 1,4

- Dioxane

- Exp Key Bioaccumulation: Aquatic/Sed iment.001

. h ttp://apps.echa.europa.eu/registered/data/dossiers/DISS

9d865c9c

- 7196

- 7016

- e044

- 00144f67d249/AGGR

- 9f16f88b

- 4007

- 4985

- 841e

bacc8c87c2bf_DISS

- 9d865c9c

- 7196

- 7016

- e044

- 00144f67d249.html#AGGR

- 9f16f88b

4007

- 4985

- 841e

- bacc8c87c2bf (Accessed November 5th, 2014).Page 36 of 54

Environment Canada, and Health Canada. 2010. Screening Assessment for the Challenge 1,4

- Dioxane

. http://www.ec.gc.ca/ese

- ees/789BC96E

- F970

- 44A7

- B306

- 3E324 19255A6/batch7_123

- 91

- 1_en.pdf

.
European Chemicals Bureau. 2002. European Union Risk Assessment Report 1,4

- Dioxane Final Report

. http://echa.europa.eu/documents/10162/a4e83a6a

- c421

- 4243

- a8df

3e84893082aa

. Franz, C. (ACC). Monitoring Data from 2001 to 2003 File Name “14 Dioxane Occup Monitoring Data Manufasbyproductsubmittal 2014.Xlsx”. Personal communication with: Stedeford, T. (E PA, Washington, DC), 6/16/14.

Fujiwara, T., T. Tamada, Y. Kurata, Y. Ono, T. Kose, Y. Ono, F. Nishimura, and K. Ohtoshi. 2008. Investigation of 1,4

- Dioxane Originating from Incineration Residues Produced by Incineration of Municipal Solid Waste . Chemosphe re, 71, 894

- 901.

Hansch, C., A. Leo, and D. Hoekman. 1995. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society.

Howard, P. 1990. Handbook of Environmental Fate and Exposure Data for Organic Chemicals

. Chelsea, MI: Lewis Publishers.

IARC (International Agency for Research on Cancer). 1976. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Conside rations on Volatile Anaesthetics. Volume 11 . World Health Organization, Lyon. France.

Kelley, S., E. Aitchison, M. Deshpande, J. Schnoor, and P. Alvarez. 2001. Biodegradation of 1,4

- Dioxane in Planted and Unplanted Soil: Effect of Bioaugmentation with Am ycolata Sp. Cb1190 . Water Research, 35(16), 3791

- 3800.

Lewis, R., Sr. 2000. Sax's Dangerous Properties of Industrial Materials (10th ed.). New York, NY: John Wiley & Sons, Inc.

Lide, D. 2008

- 2009. CRC Handbook of Chemistry and Physics (89th ed.). Boca Ra ton, FL: CRC Press.

Lyman, W., W. Reehl, and D. Ronsenblatt. 1982. Handbook of Chemical Property Estimation Methods (Ch 8, P 8

- 4)

. Minnesota Department of Health (MDH). 2013. Chemicals of High Concern List

. http://www.health.state.mn.us/divs/eh/hazardous/topics/toxfreekids/chclist/mdhchc2 013.pdf (accessed July 9, 2014).Page 37 of 54

NAS/COT Subcommittee for AEGLs. 2005. Interim Acute Exposure Guideline Levels (Aegl s) 1,4

- Dioxane

. http://www.epa.gov/oppt/aegl/pubs/1_4_dioxane_interim_de_feb2005_c.pdf

. NIH (National Institutes of Health). 2006. Hazardous Substances Database (HSDB) . N ational Library of Medicine (NLM). Toxicology Data Network (TOXNET). http://toxnet.nlm.nih.gov/cgi

- bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+123

- 91

- 1 (November 5 th, 2014).

NTP (National Toxicology Program). 2014. Report on Carcinogens, Thirteenth Edition

. http://ntp.niehs.nih.gov/pubhealth/roc/roc13/index.html

.
O'Neil, M., P. Heckelman, C. Koc h, K. Roman, C. Kenny, and M. D'Arecca. 2006. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (14th ed.). Whitehouse Station, NJ: Merck & Co., Inc.

OSHA (Occupational Safety and Health Administration). 2014. Chemical Exposure Health Data for 1,4

- Dioxane (2000

- 2014) . https:// www.osha.gov/opengov/healthsamples.html

.
Pall Corporation. 2004. Final Feasibility Study & Proposed Interim Response Plan for the Unit E Plume, June 1, 2004 . Pall Corporation. http://www.michigan.gov/documents/deq/deq

rrd

- GS

- GelmanSciencesFSTextCh1

- 2_287073_7.pdf

.
Reynolds, T. 1989. Comparative Effects of Heterocyclic Compounds on Inhibition of Lettuce Fruit Germination . Journal of Experimental Botany, 40(212), 391

- 404. (ECHA (European Chemicals Agency). 2014b. 1,4

- Dioxane

- Exp Key Long

- term toxicity to aquatic invertebrates.001).

Simonich, S. M., P. S un, K. Casteel, S. Dyer, D. Wernery, K. Garber, G. Carr, and T. Federle. 2013. Probabilistic Analysis of Risks to Us Drinking Water Intakes from 1,4

- Dioxane in Domestic Wastewater Treatment Plant Effluents . Integr Environ Assess Manag, 9(4), 554

- 559.

Skad sen, J. M., Rice, B.L., and Meyering, D.J., . 2004. The Occurrence and Fate of Pharmaceuticals, Personal Care Products and Endocrine Disrupting Compounds in a Municipal Water Use Cycle: A Case Study in the City of Ann Arbor . City of Ann Arbor, Water Utilit ies and Fleis & VandenBrink Engineering, Inc., Ann Arbor, MI. http://www.a2gov.org/departments/water

treatment/Documents/Archive/PPCP_Study_Novemb er_2004.pdf

.

State of California. 2010. Chemical Lists . Department of Toxic Substances Control. https://dtsc.ca.gov/SCP/ChemList.cfm (accessed on July 29, 2014).Page 38 of 54

Tanabe, A., and K. Kawata. 2008. Determination of 1,4

- Dioxane in Household Detergents and Cl eaners . J AOAC Int, 91(2), 439

- 444.

Ullman's. 2012. Dioxane. In Wiley

- VCH, Ullman's Encyclopedia of Industrial Chemistry (Vol. 11, pp. 309

- 314).

US DHHS (Department of Health and Human Services). 1993. Hazardous Substances Data Bank (HSDB, Online Databas e) . National Toxicology Information Program, National Library of Medicine, Bethesda, MD.

US EPA (Environmental Protection Agency). 1998. Guidelines for Ecological Risk Assessment

. EPA/630/R

- 95/002F. Risk Assessment Forum.

US EPA (Environmental Protection Agency). 1999. Integrated Risk Information System (IRIS) on 1,4

- Dioxane . National Center for Environmental Assessment, Office of Research and Development, Washington, DC.

US EPA (Environmental Protection Agency). 2000. 1,4

- Dioxane Hazard Summary . Office of Air and Radiation TTN

- Air Toxics Web site. http://www.epa.gov/ttn/atw/hlthef/dioxane.html (2/16/2014).

US EPA. 2006a. Non

- Confidential 1988

- 2002 Inventory Up date Reporting (IUR) Production Volume Data

. http://www.epa.gov/cdr/tools/data/2002

- vol.html (January 13, 2014).

US EPA (Environmental Protection Agency). 2006b. Treatment Technologies for 1,4

- Dioxane: Fundamentals and Field Applications . EPA

- 542

- R

- 06

- 009. Office of Solid Waste and Emergency Response. http://costperformance.org/remediation/pdf/EPA

Treatment _of_1,4

- Dioxane.pdf

. US EPA (Environmental Protection Agency). 2009. Interpretive Assistance Document for Assessment of Discrete Organic Chemicals

- Sustainable Futures Summary Assessment

- Updated September 2009

. http://www.epa.gov/opptintr/sf/pubs/iad_discretes_092009.pdf

.

US EPA. 2010. Non

- Confidential 2006 Inventory Update Reporting (IUR)

. http://cfpub.epa.gov/iursearch/2006_iur_companyinfo.cfm?chemid=3705&outchem=b oth (August 4, 2014).

US EPA (Environmental Protection Agency). 2012a. 2012 Edition of the Drinking Water Standards and Health Advisories . EPA 822

- S

- 12

- 001. http://water.epa.gov/action/advisories/drinking/upload/dwstandards2012.pdf

.

US EPA. 2012b. Non

- Confidential 2012 Chemical Data Reporting (CDR)

. http://java.epa.gov/oppt_chemical_search/Page 39 of 54

US EPA (Environmental Protection Agency). 2012c. Toxics Realease Inventory (TRI) Explorer Query for 1,4

- Dioxane for 2012 Reporting http://iaspub.epa.gov/triexplorer/tri_release.chemical (2/16/2014).

US EPA. 2013a. Estimation Programs Interface Suite for Microsoft Widows, V. 4.11

. http://www.epa .gov/opptintr/exposure/pubs/episuitedl.htm , as of November 5th, 2014.

US EPA (Environmental Protection Agency). 2013b. Toxicological Review of 1,4

- Dioxane (CAS No. 123

- 91

- 1) with Inhalation Update . EPA

- 635/R

- 09

- 005

- F. Integrated Risk Information System (I RIS), Washington, DC. http://www.epa.gov/iris/toxreviews/0326tr.pdf

. US EPA (Environmental Protection Agency). 2014a. Chemical Data Reporting (CDR) Basic Information

. http://epa.gov/cdr/pubs/guidance/basic.html

. US EPA (Environmental Protection Agency). 2014b. Framework for Human Health Risk Assessment to Inform Decision Making . EPA/100/R

- 14/001. Office of the Science Advisor, Washington, DC. http://www.epa.gov/raf/files/hhra

- framework

- final

- 2014.pdf

.

US EPA. 2014c. Non

- Confidential 2012 Chemical Data Reporting (CDR)

. http://www.epa.gov/cdr/ (August 18, 2014).

US EPA (Environmental Protection Agency). 2014d. Technical Fact Sheet

- 1,4

- Dioxane. EPA 505

- F

- 14

- 011. Office of Solid Waste and Emergency Response. http://www2.epa.gov/sites/production/files/2014

- 03/documents/ffrro_factsheet_contaminant_14

- dioxane_january2014_final.pdf

. US EPA (Environmental Protection Agency). 2014e. The Third Unregulated Contaminant Monitoring Rule (UCMR 3): Data Summary . EPA 815

- S

- 14

- 004. http://water.epa.gov/lawsregs/rulesregs/sdwa/ucmr/upload/epa815s15001.pdf

. US FDA (Fo od and Drug Administration). 2007. 1,4

- Dioxane

- a Manufacturing Byproduct

. http://www.fda.gov/cosmetics/productsingredients/potentialcontaminants/ucm101566 .h tm

. US FDA (Food and Drug Administration). 2011. Guidance for Industry Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision) . VICH GL18(R). Center for Veterinary Medicine. http://www.fda.gov/downloads/animalveterinary/guidancecomplianceenforcement/gui danceforindustry/ucm052441.pdf

.
Washington State. 2013. Chemicals of High Con cern to Children . Department of Ecology. http://www.ecy.wa.gov/programs/swfa/cspa/chcc.html (accessed on July 10, 2014).Page 40 of 54

Yalkowsky, S., and Y. He. 2003. Handbook of Aqueous Solubility Data (Pp 117) . Boca Raton, FL: CRC Press.



## APPEND I CES

Appendix A Regulatory and Assessment History

Table A

- 1: History of Regulatory and Assessment Actions in the U.S. and Internationally

.

COUNTRY REGULATORY /ASSESSMENT ACTION UNITED STATES Occupational Exposure Limits Occupational exposure limits are established:

 1989 OSHA PEL: 25 ppm (90 mg/m 3 ) TWA

 1994 NIOSH REL: 1 ppm (3.6 mg/m 3 ) 30

- minute ceiling, [skin]

 1993

- 1994 ACGIH TLV: 25 ppm (90 mg/m 3 ) TWA

UNITED STATES ATSDR Minimal Risk Levels (MRLs) 2013 Inhalation MRLs:

 Acute

- duration inhalation exposure (14 days or less) = 7.2 mg/m 3 (2 ppm) was derived from a NOAEL of 72 mg/m 3 (20 ppm) for eye and respiratory irritation and pulmonary function effects in humans.

 Intermediate

- duration inhalation exposure (15 to 364 days) = 0.72 mg/m 3 (0.2 ppm) was derived from a BMCL 10 of 101 mg/m 3 (27.99 ppm) (subsequently adjusted for duration) for increased incidence of nasal lesions in rats.

 Chronic

- duration inhalation exposure (365 days or more) = 0.11 mg/m 3 (0.03 ppm) was deriv ed from a LOAEL of 180 mg/m 3 (50 ppm) (subsequently adjusted for duration) for increased incidence of nasal lesions in rats (Kasai et al, 2009)

.

Oral MRLs:

 Acute

- duration oral exposure (14 days or less) = 5 mg/kg

- bw/day was derived from a NOAEL of 516 mg/kg

- bw/day for developmental and maternal effects in rats.

 Intermediate

- duration oral exposure (15 to 364 days) = 0.5 mg/kg

- bw/day was derived from a NOAEL of 52 mg/kg

- day for liver effects in rats.

 Chronic

- duration oral exposure (365 days or more) = 0.1 mg/kg

- bw/day was derived from a NOAEL of 9.6 mg/k g

- day for liver effects in rats (Kociba et al, 1974).

UNITED STATES IRIS Cancer and Non

cancer Benchmarks 2013  Cancer Slope Factor: 0.1 ( mg/kg/day ) - 1 (based on Kano et al, 2009)

 Drinking Water Unit Risk: 2.9 × 10 - 6 μg/L

 Inhalation Unit Risk: 5 × 10 - 6 (μg/m 3 ) - 1

 RfD = 0.03 mg/kg

- day based on degenerative liver effects as the most sensitive endpoint observed in a chronic bioassay ; point of departure = 9.6 mg/kg

- day (Kociba et al, 1974)

 RfC = 3.0 × 10 - 2 mg/m 3 (0.0083 ppm) based on co

- critical effects of olfactoryPage 41 of 54 COUNTRY REGULATORY /ASSESSMENT ACTION epithelium atrophy and respiratory metaplasia in rats exposed for 2 years via inhalation ; point of departure = 32.2 mg/m 3 (Kasai et al, 2009)

.

 http ://www.epa.gov/iris/subst/0326.htm

UNITED STATES Drinking Water Limits 2012  Health advisory levels for 1,4

- dioxane in drinking water: 4 mg/L (one

- day, 10

- kg child), 0.4 mg/L (ten

- day, 10

- kg child), 1 mg/L (DWEL), 0.2 mg/L (Life

- time), and 0.035 mg/L at 10 - 4 cancer risk. (USEPA, 2012)

 On the EPA Unregulated Contaminant Monitoring Rule 3 (UCMR3) list.

UNITED STATES Cancer Classification  EPA

- classified as B2

- Probable human carcinogen (EPA 2003)

- “1,4

- dioxane is ‘likely to be carcinogenic to humans’ based on evidence of carcinogenicity in several 2

- year bioassays conducted in four strains of rats, two strains of mice, and guinea pigs.

 The National Toxicology Program concluded that 1,4

- dioxane is 'reasonably anticipated to be a human carcinogen' (NTP 2005).

 IARC classifies 1,4

- dioxane as 'possibly carcinogenic to humans' (IARC 1999

UNITED STATES Hazardous Air Pollutant  L isted as a hazardous air pollutant under the Clean Air Act (CAA)

UNITED STATES Wastes, Releases, and Remediation  May be regulated as hazardous waste when used as a solvent stabilizer

 R eportable quantity of 100 pounds has been established under CERCLA

 Facilities ma nufacturing, processing, or otherwise using 1,4

- dioxane are required to report releases to EPA’s Toxic Release Inventory (TRI).

UNITED STATES Food and Drugs  FDA set l imits of 10 ppm in approving glycerides and polyglycerides for use in dietary supplements , and for spermicides.

EUROPEAN UNION 2002 The European Union Risk Assessment Report (EU RAR) concluded that:

 Environmental risk, risk to consumers
, and risk to general population s are not expected.

 Risks a re expected to workers due to: (i) skin effects during production, formulation and use of the substance or the product containing the substance, and (ii) systemic toxicity and carcinogenicity due to dermal exposure from the use of the substance as cleaning agent, and due to inhalation during formulation of the substance.

CANADA 2010  Environment Canada (2010) assessed risks to human health based on potential exposure and carcinogenicity and concluded that 1,4

- dioxane is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Australia 1998  Priority existing chemical, report published in 1998.

 The occupational risk assessment concluded that, for known Australian work situations, 1,4

- dioxane is unlikely to cause acute or chronic adverse effects, including i nhalation and dermal exposure. However, estimated exposure based on modeled data to workers involved in optical lens manufacture indicate a potential risk.

 The public health risk assessment concluded there are no significant health risk s to the general public from the only source of potential exposurePage 42 of 54 COUNTRY REGULATORY /ASSESSMENT ACTION (consumer products containing 1,4

- dioxane as impurity).

 The environmental risk assessment indicated that the ma jority of 1,4

- dioxane will be released to wastewater , and that the chemical does not present a significant risk of adverse effects to the Australian aquatic environment.

Japan  Priority Assessm ent Chemical Substance (PACS). PACS are substances whose long

- term toxicity to humans or to flora and fauna in the human living environment is unclear, that have been found, or are expected to be found, inconsiderable amounts over a substantially exte nsive area of the environment. These substances are designated as c hemicals that require a priority assessment to assess the risk they may pose.)Page 43 of 54



## Appendix B Summary of Uses and End Products

Table B

- 1 : Summary of All Uses of 1,4

- Dioxane and End Products

.

Use End Product(s) Processing s olvent  Waxes

 Fats

 Lacquers and varnishes

 Cleaning and detergent preparations

 Adhesives

 Cosmetics*

 Deodorant fumigants

 Emulsions and polishing compositions

 Wood pulp Reaction m edium s olvent  Organic chemicals I ndustrial solvent with an unspecified function  Fluid for scintillation counter (radiation detector) samples

 Specific applications in biological procedures (histology)

 Cellulose acetate membranes used as filters

 Dye baths

 Lacquers and paints

 Waxes

 Varnishes and stains

 Printing compositions

 Paint and varnish removers

 Laboratory reagent (e.g., mobile phase in chromatography) Extraction medium  Animal and vegetable oils Inert ingredient  Pesticides and fumigants Chemical intermediate  Pharmaceuticals

 PET plastic

 Rubber

 Insecticides and herbicides

 Cements

 Deodorant fumigants

 Magnetic tape

 Adhesives Polymerization catalyst  Plastics (unspecified plastic type) Dehydrating agent  Unknown Wetting and dispersing agent  Textiles Degreasing agent  Unknown Unintentional Impurity  Food (as a result of food additives or pesticides)

 Cosmetics

 Agricultural/veterinary products

 Industrial detergents

 Household detergents

 Pharmaceuticals

 Antifreeze and deicing products *As listed in ECHA, 2002 and not confirmed by US sources. Sources: EPA, 2006; ASTDR, 2012 ; ECHA, 2002 ; FDA, 2007; Environment Canada, 2010Page 44 of 54



## Appendix C Occupational Exposure Data

Appendix C contains US occupational exposure inhalation data from two sources.

Table C

- 1 : Summary of 1,4 Dioxane Occupational Monitoring Data for Process Operators in the Synthesis Area from an ACC Member Company where 1,4

- D ioxane is Produced as a B yproduct in its M anufacturing P rocess.

Sample Date Activity Results (ppm, 8

- hour TWA) 10/29/01 Emptying & Boiling out Vessel LT 0.044 10/29/01 Emptying & Boiling out Vessel LT 0.054 10/29/01 Emptying & Boiling out Vessel LT 0.045 10/29/01 Emptying & Boiling out Vessel LT 0.045 10/29/01 Emptying & Boiling out Vessel LT 0.046 10/29/01 Emptying & Boiling out Vessel LT 0.043 10/29/01 Emptying & Boiling out Vessel LT 0.046 07/11/02 Running PO and EO into [Product] batch LT 0.1 05/29/03 Drumming [Product] LT 0.9 06/03/03 Drumming [Product] LT 0.3 06/09/03 Sampling and Drumming [Product] LT 0.3

06/09/03 Adding [Raw Material] to [Product] LT 0.3 06/11/03 Drumming [Product] LT 0.3 06/13/03 Drumming [Product] LT 0.3 06/16/03 Sampling and Drumming [Product] LT 0.3 06/19/03 Drumming [Product] LT 0.4 06/23/03 Sampling [Product] LT 0.3 07/02/03 Sampling and Drumming [Product] LT 0.3 07/06/03 Dumping P2O5 into [Product] LT 0.3 07/09/03 Drumming [Product] LT 0.3 07/14/03 Drumming [Product] LT 0.3 Source: Franz, 2014. Key: LT = Less than (the value provided is the limit of detection (LOD))

. TWA = time weighted average over an 8

- hour periodPage 45 of 54

Table C

- 2 : 1,4

- Dioxane

- OSHA Chemical Exposure Health Data, 1997

– 2011

.

Establishment

City

State Zip Date

SIC NAICS Type Time

(minutes) Result

(ppm) Peter Cremer North America, Lp Cincinnati OH 45204 15

- May

- 08 2869 325199

D46774 P 15 ND

Peter Cremer North America, Lp Cincinnati OH 45204 15

- May

- 08 2869 325199

D46775 P 19 ND

Peter Cremer North America, Lp Cincinnati OH 45204 15

- May

- 08 2869 325199

D46773 P 15 ND

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77374 P 32 ND

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77370 P 65 ND

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77372 P 30 ND

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77368 P 60 ND

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77369 P 84 0.2117

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77371 P 50 0.2242

Crystal, Inc.

- Pmc Lansdale PA 19446 16

- Jun

00 2841 0 E77373 P 60 ND

Tex

- Tube, Inc. Houston TX 77024 13

- Jul

98 3498 0 E65998 P 18 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63443 A 75 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63444 A 40 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63441 A 75 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63440 A 75 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63442 A 75 ND

Raytheon Aircraft Company Wichita KS 67206 2

- Apr

98 3721 0 E63439 A 75 ND

Yellow Freight Systems, Inc. Columbus OH 43228 9

- Mar

98 4231 0 J61640 P 17 ND

Yellow Freight Systems, Inc. Columbus OH 43228 9

- Mar

98 4231 0 J61642 B 0 ND

Yellow Freight Systems, Inc. Columbus OH 43228 9

- Mar

98 4231 0 J61639 P 25 ND

Baker Petrolite Sand

Springs OK 74063 17

- Feb

98 2869 0 P 225 ND

Source: https://www.osha.gov/opengov/healthsamples.html accessed 3/7/14 Key: SIC = Standard Industrial Classification; NAICS = North American industrial Classification System; ND = Not Detected; Types: P = Personal, A = Area, B = Bulk The detection limits for samples labeled as ND are not given.Page 46 of 54



## Appendix D Ecological Hazard Studies

The ecological hazard summary of 1,4

- dioxane is based on availa ble hazard data. In addition, an updated literature survey was conducted to identify articles on eco logical toxicity published between 2003 and 2014. The search terms included freshwater and saltwater fish, aquatic invertebrates, and aquatic plants; pelagic and benthic organisms; acute and chronic sediment toxicity in freshwater and saltwater and terrestrial tox icity to soil organisms, birds, and mammals. The test species, test conditions, toxicity endpoints, statistical significance, and strengths/limitations of the study were evaluated for data quality.

1,4

- dioxane has been tested for acute and chronic aquati c toxicity. In order to characterize the effects of 1,4

- dioxane to the environment, a hazard rating was assigned based on EPA methodology for existing chemical classification ( US EPA , 2009 ) . Included in this assessment are eight acute aquatic toxicity studies and three chronic aquatic toxicity studies. There is one study that characterizes the toxicity of 1,4

- dioxane for aquatic plants. Acute and chronic toxicity data for 1,4

- dioxa ne exist for freshwater and saltwater fish, daphnia, and green algae. There are no available sediment, soil, or avian toxicity studies found in literature for 1,4

- dioxane. Also, EPA/OPPT agrees with the classification of studies prev iously reviewed in the EU RAR ( European Chemicals Bureau, 2002 ) . The European Chemicals Agency (ECHA) database on 1,4

- dioxane contains updated hazard studies that were used to supplement the EU RAR

.

A summ ary of the available ecotoxicity data for 1,4

- dioxane is provided below. The data show that there is a low acute and chronic ecotoxicity for fish, aquatic invertebrates and aquatic plants Hazard to soil and sediment organisms are expected to be low based o n the lack of partitioning to and persistence in th ese environment al compartments . The EU RAR ( European Chemicals Bureau, 2002 ) also concluded low hazard for soil and sediment organisms.



### D

- 1 Acute Toxicity to Aquatic Organisms

Acute aquatic toxicity studies considered for this assessment are summarized in Table D

- 1. Based on the available studies, fish, invertebrates and algae, 1,4

- dioxane exhibits low acute toxicity for aquatic species.Page 47 of 54

Table D

- 1 : Aquatic Toxicity Data for 1,4

- Dioxane

- Acute Toxicity

.

Test Species Fresh/ Salt

Water Duration End

point Conc

. (mg/L) Test

Analysis Effect References

Fish Bluegill sunfish ( Lepomis macrochirus ) Fresh 96

- hour LC 50 >1,000 Nominal Mortality Dawson et al. (1977) as cited in Verschueren, (2010) Fathead minnow ( Pimphales promelas ) Fresh 96

- hour LC 50 1,080 to 9,850 Measured Mortality Geiger, et al. (1990) Fathead minnow ( Pimphales promelas ) Fresh 96

- hour LC 50 9,872 Measured Mortality Brooke (1987)

Fathead minnow ( Pimphales promelas ) Fresh 96

- hour LC 50 12,326 Nominal Mortality Brooke (1987)

Fathead minnow ( Pimphales promelas ) Fresh 96

- hour LC 50 >100 Nominal Mortality Dow (1991) as cited in the EU RAR (2002) Inland Silversides ( Menidia beryllina ) Salt 96

- hour LC 50 67,000 Nominal Mortality Dawson et al. (1977) Aquatic Invertebrates

Water flea ( Daphnia magna ) Fresh 48

- hour EC 50 >1,000 Nominal Immobilization ECHA Assessment Report (2014) Water flea ( Ceridodaphnia dubia ) Fresh 48

- hour EC 50 >299 Nominal Immobilization Dow (1989) as cited in the 2002 EU RAR

Acute Toxicity to Aquatic Invertebrates For this assessment, there are two studies on the acute ecotoxicity to aquatic invertebrates. The water flea ( Daphnia magna ) were exposed to unspecified concentrations of 1,4

- dioxane for 48

- hours under semi

- static conditions. The highest concentration tested was 1,000 mg/L. No effects were seen at the highest concentration of 1,000 mg/L. A 48

- hour EC 50 of >1,000 mg/L was reported ( European Chemicals Bureau, 2002 ) . In the other study, Ceridodaphnia dubia was tested under the same conditions. A 48

- hour EC 50 of >299 mg/L was reported (Dow Chemical, 1989). These values show that the acute toxicity of 1,4

- dioxane to aquatic invertebrates is low.

A cute Toxicity to Fish The acute 96

- hour LC 50 values range s from >100 mg/L for fathead minnows ( Pimephales promelas ) to 67,000 mg/L for the Inland Silversides ( Menidia beryllina ). Overall, the acute toxicity of 1,4

- dioxane to fish is low ( European Chemicals Bureau, 2002 )

.Page 48 of 54



### D

- 2 Chronic Toxicity to Aquatic Organisms

Table D

- 2 : Aquatic Toxicity Data for 1,4

- Dioxane

- Chronic Toxicity

.

Test Species Fresh/ Salt Water Duration End

point Conc

. (mg/L) Test Analysis Effect References

Aquatic Plants
Green algae ( Pseudokirchnerella subcapitata ) Fresh 72

- hour EC 50 580 unspecified growth ECHA Assessment Repor t, 2014 1,000 biomass Aquatic Invertebrates

Water flea ( Daphnia magna ) Fresh 21

- day NOEC >1,000 Unspecified Reproduction ECHA Assessment Repor t, 2014 Fish Medaka ( Oryzias latipes )

Fresh 28

- day NOEC 565 Measured Not Reported Johnson et al. (1993) as cited in EPA’s Ecotox Database, 2014 Fathead minnow ( Pimphales promelas ) Fresh 32

- day MATC 145 Measured Development, Hatching, Survival TSCATS, (1989)

as cited in the EU RAR (2002)

Toxicity to Aquatic Plants Only one adequate study is available to characterize the toxicity of 1,4

- dioxane to aquatic plants. Green algae ( Pseudokirchnerella subcapitata ) were exposed to unspecified concentrations of 1,4

- dioxane for 72

- hours under static conditions. No effects were observed on growt h rate or biomass at 1,000 mg/L, the highest concentration tested. A 72

- hour EC 50 (growth rate and biomass) of > 1,000 mg/L (growth rate) was reported. A NOEC of 580 mg/L (biomass) and a NOEC of 1,000 mg/L were reported (ECHA Assessment Report, 2014). Thi s study indicates the toxicity of 1,4

- dioxane to aquatic plants is low.

Chronic Toxicity to Aquatic Invertebrates One study is available that characterizes the chronic toxicity of 1,4

- dioxane to aquatic invertebrates. Water fleas ( D. magna ) were exposed t o unspecified concentrations of 1,4

- dioxane in a 21 day reproduction test. The exposure conditions were not reported. The highest exposure concentration tested was 1,000 mg/L. No effects on reproduction, survival or growth were reported. A 21

- day NOEC of >1,000 mg/L was reported (ECHA Assessment Report, 2014). The reported NOEC indicates the chronic effects of 1,4

- dioxane to aquatic invertebrates is low.

There are no available studies on the toxicity of 1,4

- dioxane to sediment

- dwelling organisms. EPA /OPPT agrees with the EU RAR ( European Chemicals Bureau, 2002 ) that there is low potential of 1,4

- dioxane to adsorb to sediment and elevated levels are not expected in sediments

.Page 49 of 54

Chronic Toxicity to Fish There are three available studies that characterize the chronic toxicity of 1,4

- dioxane to freshwater fish. Medaka ( Oryzias latipes ) were exposed to measured concentrations of 1,4

- dioxane ranging from 565 to 6,933 mg/L for 28 days under flow

- through conditions. The effects on growth and survival were reported (Johnson et al., 1993). No effects were seen. A no observed effect concentration (NOEC) of 565 mg/L was reported. In another study, f athead minnows ( P. promelas ) were exposed to mean measured concentrations of 27.6, 40.3, 65.3, 99.7, and 145 mg/L of 1,4

- dioxane to observe the effects of the chemical on hatching, development and survival for 32 days under flow

- through conditions. 1,4

- dioxane had no significant effects on embryo development, hatching, la rvae su rvival or larvae weight. A NOEC of >103 and a maximum acceptable toxicant concentration (MA TC) of >145 mg/L were reported ( European Chemicals Bureau, 2002 )

.



### D

- 3 Terrestrial Plants Toxicity

One study was found that characterizes the hazard of 1,4

- dioxane to terrestrial plants. Lettuce ( Actuca sativa ) was exposed to 1,4

- dioxane in a germination/root elongation toxicity test for 3

- days. An EC 50 of 1,450 mg/L was reported for germination ( Reynolds, 1989 ) . This is a non

guideline study. Currently, EPA has no available hazard criteria that applies to this endpoint.



### D

- 4 Soil Invertebrate and Avian Toxicity

There are no available acute or chronic toxicity studies that characterize the hazard of 1,4

- dioxane to soil or terrestrial organisms. However, the toxicity of 1,4

- dioxane is expected to be low in these environments based on the chemical’s high vapor pressure and it’s propensity to volatilize from soil. 1,4

- dioxane is slightly volatile from water surfaces and moist soil due to its high water solubilit y. No toxicity data are available for 1,4

- dioxane to birds.Page 50 of 54



## Appendix E Human Health Hazard S tudies

The human health studies summarized here and in Table E

- are referenced in the EPA IRIS Toxicological Review of 1,4

- Dioxane (with Inhalation Update) available at: http://www.epa.gov/IRIS/t oxreviews/0326tr.pdf

.



### E

- 1 Acute Toxicity Studies

Mortality was observed in multiple acute high

- dose studies in rats , rabbits, and mice via the oral, dermal, or inhalation route . The oral LD 50 values calculated for rats ranged from 5,170

– 7,339 mg/kg

- bw ; t he dermal LD 50 in rabbits is equal to 7,885 mg/kg

- bw , and the inhalation LC 50 in mice is equal to 36,700 mg/m 3 and ranged from 46,000

– 52,000 mg/m 3 in rats.



### E

- 2 Repeated

- Dose Toxicity Studies

Oral Toxicity A 90

- day oral repeated

- dose toxicity study in male and female F344 rats and BDF1

- mice with 1,4

- dioxane in drinking water ( Kano et al, 2008 ) showed a dose

- depended increase in the relative weights of the kidney and lung in rats and mice with a relative liver weight increase only in rats. A no

- observed

- adver se

- effect level (NOAEL) was determined at 170 mg/kg

- bw/day in mice and 52 mg/kg

- bw/day in rat.

Kociba et al (1974), conducted a study in which Sherman rats were administered 1,4

- dioxane in drinking water for up to 716 days. No treatment

- related effects we re observed at the lowest dose tested for either sex. Both sexes that were treated at the mid

- dose, showed variable degrees of renal and hepatic degenerative changes with no occurances of tumors. Hepatocellular and renal degenerative changes, and hepatocel lular and nasal carcinomas observed at the highest dose were considered equivalent to previous reported study results. A LOAEL of 94 mg/kg

- bw/day and a NOAEL of 9.6 mg/kg

- bw/day were determined.

Dermal Toxicity The 90

- day study conducted by Kasai et al ( 2008) via inhalation does not provided appropriated details of the dermal toxicity of 1,4

- dioxane.

Inhalation Toxicity A 90

- day repeated

- dose toxicity study with F344 with vaporized 1,4

- dioxane for 6 hours/day and 5/days/week as reported by Kasai (2008)
, showed mortality at the highest dose tested. Histopathological changes in the liver, kidney
, nasal epithelium
, and lung were observed at 360 mg/m 3 . A LOAEC of 360 mg/m3 is based on histopathological changes in the liver, kidney
, nasal epithelium
, and lung.Page 51 of 54



### E

- 3 Reproductive and Developmental Toxicity Studies

No reproductive toxicity studies have been performed; however, no histopathological changes were reported in the reproductive organs of male and female rats/mice exposed to 1,4

- dioxane in subchron ic and chronic studies, which suggests a low concern for reproductive toxicity.

Pregnant female Sprague Dawley rats given 1,4

- dioxane by oral gavage in water on gestation days 6

- 15, showed decreases in maternal body weight gain at 1000 mg/kg

- bw/day (Giavi ni et. al., 1985) . A slight decrease in fetal weight and ossification of the sternebrae was also observed at 1000 mg/kg

- bw/day.



### E

- 4 Skin Irritation and Sensitization Studies Clark et al (1994) conducted a dermal irritation assay where male (COBS/Wister rats (number not stated) were shaved on specific areas of the back and flank then exposed to a single dose of 1,4

- dioxane at 8,300 mg/kg and observed for 14 days. No treatment

- related effects were observed.

The 90

- day study conducted by Kasai et al (2008) via inhalation does not provide appropriate details of the dermal toxicity of 1,4

- dioxane.



### E

- 5 Genot oxicity and Cancer Studies

The genotoxic potential of 1,4

- dioxane has been evaluated using in vitro and in vivo assay systems. The majority of in vitro assays with 1,4

- dioxane were nongenotoxic. Fifty

- percent of in vivo studies with 1,4

- dioxane were positive. EPA’s IRIS program concluded that 1,4

- dioxane is nongenotoxic or weakly genotoxic based on reviewed gene mutation and chromosome aberration studies

. In the Kociba et al (1974) repeated

- dose oral drinking water study in rats previously mentioned, 1,4

- dioxane increased tumor progression in the liver via the oral route.

Kasai et al (2009) conducted a two

- year bioassay in male F344 rats exposed to 1,4

- dioxane via vapor inhalation at various concentrations for 6 hours/day, 5/days/week. Mortality was observed at the mid

- and high dose. A statistically significant dose

- dependent increase in nasal squamous cell carcinomas, hepatocellular adenomas, and perit oneal mesotheliomas were observed predominantly at the high dose. Renal cell carcinomas, mammary gland fibroadenomas, and adenomas were observed in a dose

- dependent manner. Nasal cavity and liver preneoplastic lesions were observed at all doses. At 50 ppm, nonneoplastic lesions, nuclear enlargement, atrophy, and respiratory metaplasia in the nasal cavity were significantly increased. 1,4

- Dioxane increased the incidence of tumors in rats.Page 52 of 54

The IRIS cancer slope factor (CSF) was based on the development of li ver tumors in female mice (Kano et al, 2009). In this study, male and female F344/DuCrj rats and Crj:BDF(1) mice were exposed up to 5000 ppm (rats) and 8000 ppm in mice of 1,4

- dioxane in the drinking water for 2 years. A significant induction of nasal squa mous cell carcinomas (females), hepatocellular adenomas and carcinomas (males and females), peritoneal mesotheliomas (males), and mammary gland adenomas (females) were observed. Mice showed a significant induction of hepatocellular tumors in males and fema les.

In a supporting study (NCI
, 1978), Osborne

- Mendel rats (0, 240, and 530 mg/kg

- bw/day

- males; 0, 350 and 640 mg/kg

- bw/day

- females) and B6C3F1 mice (0, 720, and 830 mg/kg

- bw/day

males; 0, 380, and 860 mg/kg

- bw/day

- females) were exposed to 1,4

- dioxane (v/v) via drinking water for 2

- years. 1,4

- Dioxane induced squamous

- cell carcinomas of the nasal turbinates in treated rats and hepatocellular carcinomas in treated mice.Page 53 of 54

Table E

- 1 : Human Health Endpoints for 1,4

- Dioxane

.

Endpoint Hazard Determination References ( all are as cited in ( US EPA, 2013b ) ) Acute Oral Toxicity LD 50 (mg/kg

- bw) 5,170

– 7,339 (rat) Laug et al. (1939); Smyth et al. (1941); Nelson (1951); Pozzani et al. (1959); JBRC (1998) Acute Dermal Toxicity LD 50 (mg/kg

- bw) 7,885 (rabbit) Clark et al. (1984)
Acute Inhalation Toxicity LC 50 (mg/L) 36,700 ( mouse ) Fairley et al. (1934); Wirth and Klimmer (1936)
46,00

– 52,000 (rat) Failey et al. (1934); Nelson (1951); Pozzani et al. (1959) Repeated

- Dose Toxicity

Oral (mg/kg

- bw/day)

Inhalation (mg/L/day) NOAEL = 170 mg/kg

- bw/day (mice); NOAEL = 52 mg/kg

- bw/day (rat) Moderate hazard via the oral route based on histopathological changes in the liver, kidney and bronchial epithelium Kano et al. (2008 and 2009)

LOAEL = 94 mg/kg

- bw/day; NOAEL = 9.6 mg/kg

- bw/day (rat) High hazard based on degeneration and necrosis of renal cells and hepatocytes (non

- cancer) Kociba et al (1974). Endpoint used as the point of departure (POD) for the IRIS Reference Dose (RfD). NOAEC = 360 mg/m 3 (rat) Moderate hazard via the inhalation r oute based on histopathological changes in the liver, kidney, nasal epithelium, and lung Kasai et al. (2008)

Developmental Toxicity NOAEL = 500; LOAEL = 1,000 mg/kg

- bw/day Low hazard based on delayed ossification of the sternebrae and reduced body weights in rats Giavini et al. (1985)

Reproductive Toxicity No specific reproductive studies have been performed Low hazard based on no histopathological changes in reproductive organs of male and female mice in subchronic and chronic s tudies. Giavini et al. (1985)

Genetic Toxicity, gene mutation In vitro Nongenotoxic Low hazard based on available in vitro studies Morita and Hayashi (1998); Stott et al. (1981); Hellmer and Bolcsfoldi (1992); Zimmerman et al. (1985)Page 54 of 54 Endpoint Hazard Determination References ( all are as cited in ( US EPA, 2013b ) )

In vivo Nongenotoxic or weakly genotoxic Low hazard based on available in vitro and in vivo studies Roy et al. (2005); Morita and Hayashi (1998); Stott et al. (1981) Genetic Toxicity, chromosomal aberrations

In vitro

In vivo Nongenoto xic Low hazard based on available in vitro studies Galloway et al. (1987); Morita and Hayashi (1998)

Nongenotoxic or weakly genotoxic Low hazard based on available in vitro and in vivo studies Miyagawa et al. (1999); Goldsworthy et al. (1991); Stott et al. (1981) Chronic (Non

- Cancer) Oral

Inhalation NOAEL = 9.6; LOAEL = 94 mg/kg

- bw/day

NOAEL = 170; LOAEL = 387 mg/kg

- bw/day Kociba et al. (1974); Giavini et al. (1985); Kano et al. (2008)

NOAEC = 360 mg/m 3 Kasai et al. (2008) Endpoint used as the POD for IRIS Reference Concentration ( RfC ) Carcinogenicity Oral

Inhalation “Likely to be carcinogenic to humans based on evidence of

carcinogenicity in several 2

- year bioassays” High hazard base on tumor progression in the liver via the oral
route Kociba et al (1974) ; Kano et al (2009); NCI (1978)

“Likely to be carcinogenic to humans based on evidence of carcinogenicity in several 2

- year bioassays” High hazard base on tumor progression tumor progression at multiple sites via inhalation Kasai et al. (2009)

Dermal Irritation No t irritating Clark et al (1994)

Skin Sensitization No Data Kasai et al. (2008) Respiratory Sensitization Positive for Sensitization Kasai et al. (2009)